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Abstract 
 
The type II secretion system (T2SS) is the major terminal branch of the general secretory 
pathway in Gram negative bacteria. It is composed of an outer-membrane secretin, periplasmic 
pilin-like subunits extending from the inner and outer-membranes, an inner-membrane 
platform, and an associated cytoplasmic ATPase. The secretin is the only essential component 
in the outer membrane and is formed by a dodecameric torus of protein subunits. Secreted 
enzymes and virulence factors pass through the gated pore in the centre of the toroidal secretin 
dodecamer and out into the extra cellular milieu. 
In some species of bacteria there are auxiliary proteins that are important for correct assembly 
and formation of a functional T2SS. One such protein is GspB which, in the plant pathogen D. 
dadantii, aids transport of the secretin from the inner-membrane, through the periplasm and on 
to the outer-membrane.  In the absence of GspB, the secretin miss-locates to the inner 
membrane and a functional T2SS is not assembled.   
GspB is one of four inner-membrane proteins of the T2SS that have a single membrane-
spanning helix and periplasmic domain, the others are GspC, GspL and GspM.  The hypothesis 
is therefore that the periplasmic domain of GspB reaches out from the inner-membrane 
platform into the peptidoglycan-filled periplasm to facilitate the transport of the secretin 
subunits to the outer-membrane or to stabilize the secretin subunits once they have reached the 
outer-membrane. 
In this Thesis, I report the crystal structure of the periplasmic domain of the auxiliary protein 
GspB.  The structure is similar to the homology region of one of the other four single 
transmembrane helix proteins from the inner-membrane platform, GspC.   
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The homology region domain of GspC had been previously shown to interact with the N-
terminal domain of the secretin subunit and these observations suggests that GspB may have 
taken over or may augment the function of GspC.  Here, NMR spectroscopy was used to 
confirm an interaction between GspB and the N-terminal secretin domain and a model of the 
interaction is proposed on the basis of the available spectroscopic and biochemical 
measurements. 
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Chapter 1: Introduction to the Type II Secretion 
System and the role of GspB 
 
1.1 Bacterial Classification and Architecture of the Cell Envelope 
Structurally, bacteria can be divided in to two groups; those possessing an outer membrane 
(Figure 1.1a) and those without (Figure 1.1b). Their differential staining using Gram’s method 
has been an important way to distinguish and classify bacteria based upon this major structural 
difference, since its discovery in 1884. Gram negative bacteria possess both an inner and outer 
membrane between which lies a significantly thinner layer of peptidoglycan and thus they do 
not retain the crystal violet stain used in the Gram staining method. Gram positive bacteria 
however, have a much thicker layer of peptidoglycan and hence retain the crystal violet stain 
much more strongly (hence they stain positively using this method). 
Although bacteria are traditionally divided into the two main groups (Gram positive and 
negative) based on their Gram stain retention, this classification system can be ambiguous as 
it can refer to three different aspects, that of staining result, cell-envelope organisation, or 
taxonomic group, which do not necessarily all agree for some bacterial species. In this thesis, 
I use the term Gram negative to refer to bacteria which possess an inner and outer membrane, 
between which lies the peptidoglycan containing periplasmic space. The periplasm is a true 
cell compartment, filled with periplasmic fluid, which has a gel-like consistency (Hobot et al. 
1984). Proteins located in the periplasm are all specifically targeted with a signal sequence.  
These bacteria are also commonly referred to as diderm bacteria (Gupta R., 1998). The diderm 
bacteria can also be further differentiated between simple diderms lacking lipopolysaccharide, 
the archetypical diderm bacteria, in which the outer cell membrane contains 
lipopolysaccharide, and the atypical diderm bacteria, in which outer cell membrane is made up 
of mycolic acid (Gupta R., 2011). 
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In Gram negative bacteria, the inner membrane is comparatively symmetrical with both leaflets 
of the bilayer composed of phospholipid. The outer membrane however, is frequently 
asymmetrical, possessing mycolic acid or lipopolysaccharide in the outer leaflet and 
phospholipids in the inner leaflet (Mühlradt et al. 1975). 
Figure 1.1 Bacterial membranes  
The organization of membranes at the cell surface in Gram negative (A) and Gram positive (B) 
bacteria. Note the substantially thicker cell wall (made of peptidoglycan) found in Gram 
positive bacteria, which results in them retaining the crystal violet stain much more strongly 
than Gram negatives. 
 
Bacterial secretion systems allow them to interact with their environment by secreting proteins 
which may act as toxins or enzymes and can make the external environment more favourable 
by degrading compounds as a source of nutrients or inducing uptake into host cells. Bacterial 
secretion system also contribute to efflux pumps, which have a role in the establishment of 
bacteria in the host and contribute to drug resistance (Piddock, 2006). All bacterial proteins are 
transcribed in the cytoplasm and must therefore cross various membranes in order to reach the 
extracellular milieu. The system in Gram negative bacteria is necessarily more complex than 
that of Gram positives, as they possess 2 lipid bilayers which compounds and proteins must 
cross in order to enter the external environment. Numerous different systems have evolved to 
facilitate the passage of proteins and other compounds across bacterial membranes.  
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1.2 Secretion Systems in Gram negative bacteria 
At least nine different secretion systems are known  these are called the Type 1 (I) through 9 
(IX) secretion systems (Tseng et al., 2009; Desvaux et al., 2009; McBride & Zhu, 2013) of 
which the first seven are the best characterized to date (Figure 1.2). Of these, Types I, III, IV 
and VI secrete proteins across both membranes directly in one step. For the other systems 
(Types II, V and VII), proteins intended for secretion must first cross the inner membrane into 
the periplasmic space by either the SEC or TAT pathways (Pugsley, 1993) and then be 
recognised and targeted for secretion across the outer membrane. An N-terminal signal 
sequence targets proteins to the periplasm.  
 
Figure 1.2 Summary of known bacterial secretion systems 
Simplified cartoons of the 7 bacterial secretion systems. HM: Host membrane; OM: outer 
membrane; IM: inner membrane; MM: mycomembrane; OMP: outer membrane protein; MFP: 
membrane fusion protein. ATPases and chaperones are shown in yellow.  [This figure is taken 
from Tseng et al. 2009]  
 
Proteins which cross the inner membrane have a signal sequence, whose function is to help 
direct the protein to the cytoplasmic membrane. Signal peptides in bacteria fall exclusively at 
the amino terminal and have a long hydrophobic region (H domain) that is usually preceded by 
one or more positively charged residues in a short, generally hydrophilic region (the N domain). 
Shortening or introducing charged or strongly polar residues into the H domain or eliminating 
the basic amino acids from the N domain usually reduces export efficiency (Pugsley 1993). 
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Signal peptides are processed and removed during translocation across the cytoplasmic 
membrane or by signal peptidases present in the periplasm so are therefore presumed unlikely 
to influence subsequent events in the periplasm or further transport across the outer membrane. 
 
Proteins translocated across the inner membrane by the TAT pathway arrive in the periplasm 
fully folded, whilst SEC substrates are exported as linear polypeptides to adopt their native 3 
dimensional folded state in the periplasmic space. The periplasmic space forms a discrete 
cellular compartment with its own specific properties and REDOX potential. This is an 
important feature as proteins translocated across the inner membrane by the SEC pathway will 
fold in the periplasm aided by specific ions and proteins including chaperones (Pauwels et al. 
2006), Dsb oxido-reductases (Pugsley 1992) and calcium (Jones et al.  2002). Proteins found 
in the periplasm also have a variety of other functions including nutrient binding; transport, 
folding, degradation, substrate hydrolysis, peptidoglycan synthesis, electron transport, and 
xenobiotic metabolism (Klein et al. 2005)  
 
1.3 Type II Secretion System and its Role In Disease 
The Type II Secretion System (T2SS) is unique in that it allows proteins which have adopted 
their 3D conformation in the periplasm to be secreted in a fully folded sate. Genes encoding 
the components of the T2SS machinery were first discovered in the γ-proteobacterium 
Klebsiella oxytoca and were named with the prefix ‘Pul’ as they were found necessary for the 
secretion of pullulanase, an alpha-glucanase enzyme (Pugsley and Reyss, 1990). Since its 
discovery, T2SS genes have been discovered in numerous other genera of γ-proteobacteria 
including Acinetobacter, Aeromonas, Erwinia,, Escherichia, Idiomarina, Klebsiella, 
Legionella, Methylococcis, Photobacterium, Pseudomonas, Shewanella, Vibrio, Xanthamonas, 
Xylella and Yersinia (Cianciotto 2005). 
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Subsequently T2SS genes have been discovered in the α-proteobacteria (Bradyrhizobium, 
Caulobacter, Gluconacetobacter, Mesorhizobium), β-proteobacteria (Azoarcus, Burkholderia, 
Chromobacterium, Ralstonia), δ-proteobacteria (Bdellovibrio bacteriovorus, Geobacter 
sulfurreducens) and ε-proteobacteria.  
Bacteria that use T2SS and cause disease in humans include both direct (e.g. V. cholerae) and 
opportunistic pathogens (e.g. K. oxytoca). Similarly, plant pathogens can have broad host 
ranges (e.g. R. solanacearum) or infect only specific plants (e.g. E. carotovora). Pathogenic 
bacteria with functional T2SS cause a variety of diseases; for example, in humans these range 
from pneumonia (L. pneumophila, P. aeruginosa) to urinary tract infections (E. coli) to 
dysentery (V. cholerae). The importance of T2SS to bacterial pathogenesis would appear not 
to be restricted to a particular site of infection or pathogenic process and it is likely bacteria 
use the T2SS to boost pathogenesis in various ways even when considering a single species 
and disease.  
Pathogenic processes facilitated by the T2SS include tissue destruction, cytotoxicity, 
adherence, spread and transmission. It has been shown in L. pneumophila, which infects 
macrophages, that the T2SS can facilitate pathogenesis by promoting bacterial growth in 
intracellular niches (Rossier et al 2004). In other cases of human infection, there are also 
effectors that subvert the innate immune system; for example, the StcE protease of 
enterohemorrhagic E. coli cleaves components of the complement blood clotting pathway 
(Grys et al. 2005) and the ProA/Msp protease of L. pneumophila alters polymorphonuclear 
leukocyte function (Rossier et al 2004).  
When present in bacterial pathogens, T2SS systems have usually proven to be relevant and 
crucial for pathogenesis. Often, the T2SS works along with other secretion systems to achieve 
full virulence; for example, Type II and IV secretion systems are known to function in L. 
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pneumophila (Rossier et al 2004), Type II and III secretion systems function in X. campestris 
(da Silva et al. 2002), and Type I, II, III, V and VI secretion systems are present in P. 
aeruginosa (Ma et al. 2003; Hauser, 2009; Jyot et al. 2011; Hachani et al. 2011). 
The plant pathogen Dickey dadantii contains the genes for functional Type II (Shevchik & 
Condemine, 2000) and Type III (Yang et al. 2008) secretion systems. These different secretion 
systems make D. dadantii a potent pathogen of numerous plant species. The different systems 
allow the bacteria to modify both its environment in the extra cellular space of plants (by 
degrading the cell wall as a source of nutrients) and to allow it to invade plant tissues directly 
(T3SS to directly inject effector proteins to subvert plant immune responses).  
1.4 Similarities between the T2 and T4 Secretion Systems  
 
Evidence for the ancestral relationship between the T2SS and the type IV pilus (T4P) system, 
involved in cell attachment and/or twitching motility, has grown significantly over recent years. 
It is now clear they share a common progenitor and have significant structural and functional 
similarities that point to a common origin (Ayers et al. 2010). This is similar to the relationship 
hypothesised between the bacterial flagellum and the type III secretion system. Although the 
functional details of the T2S and T4P systems are now emerging, there remain significant gaps 
in our understanding of how they are dynamically assembled in the cell envelope.  
The T2SS is also highly similar to the analogous contact independent type IV secretion system 
(T4SS). The T4SS exchanges macromolecules between cell and external milieu as does the 
T2SS (Zechner et al. 2012). This includes the pertussis toxin liberation system (Ptl), which 
secretes a complex protein toxin across the cell envelope of B. pertussis to the cell exterior 
(Weiss et al.  1993) Similarly to the T2SS, translocation of pre-proteins intended for export, 
occurs as individual subunits, which cross the IM via the Sec secretion pathway (Farizo et al. 
2002).  
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Once they reach the periplasm, the subunits associate with the OM and disulphide bond 
formation stabilizes the holotoxin. For the assembled holotoxin to traverse the OM, it must 
enter the Ptl secretion channel from the periplasm. The route of entry is not known, nor is it 
understood how this process is controlled (Zechner et al. 2012). 
Among the many challenges faced in the pursuit of a unified model for T2S and T4P function 
is the limited usage of standardized nomenclature for functionally and structurally equivalent 
proteins, both within the respective systems and across the T2ss & T4P systems. In part, this 
problem has arisen due to the identification of T4P- and species-specific components, for which 
there are no obvious equivalents in the Gsp scheme as originally proposed (Ayers et al. 2010). 
1.5 Architecture of the T2SS and Essential Components  
Nomenclature of the T2SS components can be confusing as there are many species specific 
names for the individual protein components, as the homologous systems were discovered 
simultaneously and their relationship to one-another was not fully established at the time of 
naming. For simplicity the prefix Gsp (general secretory pathway) is used. When referring to 
a particular protein, the species specific nomenclature is given in superscript. (E.g. GspDOutD 
refers to the Dickey dadantii protein OutD, a GspD homologue See Table 1.) 
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Table 1.1  The location and nomenclature of the major components of the T2SS  
The location within the 2 membranes, and the species specific nomenclature of the major 
components of the T2SS present in E. coli, V. cholera, A. hydrophilia, D. dadantii, K. oxytoca, 
P. aeruginosa and X. campestris. 
 
Type II protein secretion is also known as the main terminal branch of the general secretory 
pathway (Gsp) or secretin-dependent pathway. The system spans both the inner and outer 
membrane of Gram negative bacteria and facilitates the final stage of a two-step process in 
which proteins are first translocated across the inner membrane by the SEC or TAT pathways 
and then transported from the periplasm to the exterior through an outer membrane secretin 
pore.  
 
Dependent on the bacteria, the T2SS is composed of 12 to 16 components; GspA to GspO and 
GspS. This trans-envelope secretion machinery spans the two bacterial membranes and can be 
roughly divided into three main blocks an inner membrane platform, trans-periplasmic 
pseudopilus, and outer membrane pore (Korotkov et al., 2012), as shown in Figure 1.3.   
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Figure 1.3 Molecular model of the Type II secretion nanomachine  
The model of the GspD N-
terminal domains (PDB: 
3EZJ) is positioned within the 
V. cholerae GspD EM 
reconstruction (red surface) 
(PDB: 3EZJ and EMD: 
1763).  
 
GspC HR domain was 
aligned to GspD twelve-fold 
ring using the GspC–GspD 
co-crystal structure (PDB: 
3OSS). GspC PDZ domain 
(2I4S) is positioned near the 
GspD N3 domain, just under 
the OM.  
Minor pseudopilins 
(GspK, dark green; 
GspHIJ, light greens) 
were manually added by 
grafting helices onto V. 
cholera EpsH (PDB: 
2QV8) and ETEC 
GspIJK (PDB: 3CI0) 
structures  
GspF dimer was 
created with two EpsF 
domain-1 homodimers 
(PDB: 3C1Q).  
One each of GspL and 
of GspM periplasmic domains (PDB: 2W7V; 1UV7) were aligned to the PilO homodimer 
(2RJZ) to create the GspL–GspM heterodimer (surface from PilO dimer.)  
GspE hexamer was modeled by aligning V. cholerae EpsE domains (1P9R) onto the 
homologous domains of the P. aeruginosa PilT hexamer (3JVV).  
 
Stoichiometry and relative arrangement of inner membrane proteins is currently unknown, 
although a 6:6:6:6:12 assembly of GspE: L: M: C: D is consistent with available data. For 
model viewing, one GspF dimer, two GspL-M heterodimers, and two GspC chains are shown.  
 
[Taken from McLaughlin et al. 2012] 
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1.6 Inner Membrane  
GspC, GspL and GspM all have a single transmembrane helix with GspF the exception having 
at least three transmembrane helices.  GspE is cytoplasmic but associates with the inner 
membrane components. 
GspE 
The cytoplasmic ATPase GspE is associated with the inner membrane platform (Camberg, 
2007) and is associated with the inner membrane through the cytoplasmic domain of GspL 
binds to the extended N-domain of the assembly ATPase GspE in a species-specific fashion 
(Sandkvist et al 1995, Abendroth et al. 2005) while its periplasmic domain interacts with 
GspM.  
GspE energizes formation of a short pilus, restricted to the periplasm and composed of five 
pseudopilins GspG, H, I, J and K (Nivaskumar et al., 2014). The dynamic assembly and/or 
rotation of this pilus may facilitate the passage of folded proteins through the outer membrane 
pore composed of the secretin GspD. 
 
GspF 
The essential component GspF is fully embedded in the IM via the three TM segments 
(Robert et al. 2002, Thomas et al.1997). The cytoplasmic domain of GspF probably shares the 
same 6-helix bundle structure, which has been revealed by X-ray analysis of the N-terminal 
domain Cyto1 (Abendroth 2009). Yeast two-hybrid and pull-down studies suggest that GspF 
Cyto1 interacts with GspE and GspL, forming the so called inner membrane platform that also 
includes GspM. GspF requires GspL and GspE for full stability against proteolytic degradation. 
Although GspF is crucial in the assembly of a functional T2SS, very little is known about its 
oligomeric arrangement and structure within the membrane. 
Chapter 1: Introduction 
 
27 
 
GspL 
GspL is another essential component of the inner membrane platform and may provide the 
physical link between the ATPase GspE and the membrane and also regulate its activity as well 
as allow coupling to pilus assembly. Studies in X. campestris show that only the ATP-bound 
form of GspEXpsE interacts with GspLXpsL (Shiue et al. 2006). The last 11 residues of the 
cytoplasmic domain of GspL are crucial for cardiolipin binding, which stimulates the ATPase 
activity of GspE (Camberg et al. 2007). Notably, GspLEpsL could be cross-linked to the major 
pseudopilin GspGEpsG in Vibrio cholerae, providing further evidence for the role of ATPase in 
pseudopilus assembly on a molecular basis (Gray et al. 2011).  
 
GspM 
GspM is a bitopic IM protein that interacts with GspL (Johnson et al. 2007). It has two 
periplasmic domains which both have a ferredoxin-like fold and stabilise each other, forming 
heterodimers and help ensure the correct cellular localisation (Lybarger et al. 2009). Whilst the 
other bitopic IM protein, GspL, is essential for both fiber assembly and secretion (Campos et 
al. 2013), the deficiency of GspM still allows for assembly of the pseudopilus, which suggests 
that perhaps overproduction of other components partially compensates for its absence in at 
least one species, Pseudomonas aeruginosa (Durand et al. 2005).  
 
Recent studies suggest that GspL and GpsM interact through their TM segments, along with 
GspC and form dynamic homo- and heterodimers (Lallemand et al. 2013). Structural studies 
reveal that the GspL and GspM homologues of the Type 4 Secretion System (T4SS) of T. 
thermophilus (PilN and PilO respectively) bind the major pilins during pseudopilus elongation 
(Karuppiah et al. 2013), indicating the essential role these IMP proteins play.  
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GspC 
GspC is another bitopic, transmembrane protein anchored to the inner membrane. It has two 
periplasmic domains, the homology region (HR) near the membrane and the C-terminal PDZ 
domain that is involved in substrate specificity in the D. dadantii T2SS (Bouley et al. 2001). 
The structure of the HR domain, revealed high similarity with the T4SS lipoprotein PilP 
(Korotkov et al., 2011, Gu et al., 2012b). The transmembrane segment of GspCOutC mediates 
essential dimerization in D. dadantii (Login and Shevchik 2006), whilst the HR domain 
interacts with N0 domain of GspD as shown by the recent structural and NMR studies (Gu et 
al. 2011). This contact, between GspC and GspD is essential for function and provides a contact 
across the periplasm between the platform of the inner membrane and the outer membrane 
pore. The strength of the interaction between GspC and GspD varies between species and is 
probably the basis for the species-specificity identified in systematic exchange experiments of 
Out T2SS components of D. dadantii and P. carotovorum (Lindeberg et al. 1996).  
 
Studies in D. dadantii suggest however that this link is flexible and involves multiple dynamic 
interfaces, and also that the stoichiometry of the C–D complex might vary (Login et al. 2010). 
GspC and the periplasmic flexible domains of GspD are implicated in substrate binding and 
selection. This has been proposed based on the domain exchange studies in the Out T2SS of 
D. dadantii and P. carotovorum (Bouley et al. 2001). Further support for the roles of both 
GspC and GspD in substrate binding comes from in vitro studies showing that GspGXcpP binds 
specifically to the Xcp system substrate LasB (Douzi et al. 2011). The C-terminal PDZ/coiled-
coil motif of GspC has been implicated in these protein–protein interactions (Korotkov et al. 
2006). However, this motif is required for secretion of only a subset of substrates in the D. 
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dadantii Out T2SS (Bouley et al. 2001). In vitro, cholera toxin binds to the periplasmic secretin 
vestibule in the absence of GspC (Reichow et al.2011). 
 
1.7 Outer Membrane Secretins 
 
GspD 
The secretins are a family of proteins which form pore like structures. They are present in the 
bacterial Type II, III and IV secretion systems (Figure 1.4a) and form megadalton-sized, 
dodecameric, pore-like structures (Figure 1.4b) in the outer membrane; through which secreted 
substrates are translocated (Reichow et al., 2010).  
 
 
 
 
Figure 1.4 Domain architecture and structure of secretins  
(a) Schematic representation of the domains within secretins from various secretion and 
related systems. (b) Cartoon showing the 3D structure of a secretin pore and the arrangement 
of the N-terminal domains within it. [Adapted from Hol et al. 2012] 
 
The N-termini of secretins possess serval domains, depending on species, which protrude into 
the periplasm. In the T2SS, the majority of GspD homologues have 4 N-terminal domains (N0, 
N1, N2, and N3). The crystal structure of the first three N-terminal domains (N0, N1, N2) of 
the T2SS secretin GspD from enterotoxigenic Escherichia coli has been solved with the 
assistance of an antibody fragment  (PDB: 3EZJ). The structure shows that the three 
periplasmic GspD domains are arranged into two lobes: a compact N-terminal lobe containing 
the N0 and N1 domains, and a second lobe containing the N2 domain. The GspD domains N1 
b a 
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and N2 share the same fold, which is different from that of the N0 domain, which interacts with 
the inner membrane component GspC (Korotkov et al., 2011; Gu et al., 2012a).   
The N0 domain reveals a structure similar to the TonB-dependent receptor. The N1 and N2 
domains have a fold similar to the eukaryotic type I KH domain, which is typically involved in 
binding RNA and DNA. However, the positively charged RNA/DNA binding residues are 
absent in the secretin N1 and N2 domains.  
The N3 domain structure is not known, but it has a high degree of sequence similarity with the 
N1 and N2 domains, which suggests that the N3 domain is likely to have a fold similar to N1 
and N2. It is interesting to note that the crystal structure of the N0 and N1 domain of T3SS 
secretin reveals a different orientation to that seen in the T2SS (Korotkov, Gonen et al. 2011). 
The currently known GspD N-terminal domains structures were both solved with the assistance 
of modified antibodies, which binds both N0 and N1 and could have a sizeable influence on 
the domains orientations within the crystal lattice. 
To reach the outer membrane and to be correctly assembled, the large secretin protomers (~80 
kDa) have to pass through the densely packed periplasm and the peptidoglycan mesh network.  
A special class of carrier proteins, called pilotins, ensures the transit of secretins through the 
periplasm and their assembly into the outer membrane.   
In the T2SS the secretin, GspD, is an essential, non-interchangeable component and is the only 
integral outer membrane component (Hardie et al. 1996). It exists as a dodecameric oligomer 
with each subunit composed of a C-terminal transmembrane secretin domain, a pilotin 
interacting S-domain and three N-terminal domains termed N0 through N3.  
The C-terminal secretin domain is the most conserved domain across all secretins and is 
responsible for oligomerisation (Guilvout et al. 2011). At the time of writing the only structural 
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information comes from cryo-electron microscopy and no high resolution (X-ray / NMR) 
structures are available, but it is presumed to consist of a transmembrane β-barrel type 
structure. 
The N-terminal domains are distinct, and less conserved across different species. These 
domains extend into the periplasm and are involved in a series of interaction with both secreted 
proteins and proteins of the inner membrane platform. The N0-N1 domains have been 
crystalised in isolation (PDB: 3EZJ) and in complex with the HR domain (PDB: 3OSS). The 
N0 domain alone has also been crystalised, with P6 symmetry, and its structure modelled to 
form the C12 symmetry necessary to form a dodecamer.  
These structures revealed the N0 fold to be similar to the TonB-dependent receptor. The N1 
and N2 domains are similar to the eukaryotic type 1KH domain which is typically involved in 
DNA/RNA binding, but these residues are absent in N1 and N2 and are thus far not implicated 
in such a role.  
The S-domain of GspD is responsible for the direct interaction with the pilotin GspS (Shevchik 
and Condemine 1998). The pilotin acts as a chaperone, stabilising GspD and facilitating its 
transport across the periplasm from the inner membrane to the outer membrane in partnership 
with the Lol pathway (Collin Guilvout 2011). 
 
1.8 Assembly and biogenesis of the T2SS  
In one sense, assembly of the T2SS has been thoroughly (although largely indirectly) studied, 
given that much is known about how proteins are translocated into or across the inner 
membrane, and that many of the proteins of the T2SS are integral to the inner membrane (Facey 
& Kuhn, 2010; Froebel et al., 2011). After being assembled into this membrane via the Tat and 
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Sec/SRP systems, protein–protein interactions dictated by structure might then be likely to 
result in the spontaneous self-assembly of the inner membrane platform of the system (Dalbey 
et al., 2011). In this sense much “assembly” of the T2SS would result from the formation of 
complexes driven by the inherent shape and biophysical properties such as hydrophobicity and 
electrostatic character of the proteins involved. Beyond the critical involvement of the inner 
membrane platform, these processes may or may not require additional factors beyond those 
comprising the complexes themselves.  
 
However, understanding assembly of the T2SS is complicated by the fact that the system 
resides in both membranes and spans the entire envelope of the cell. This means that 
components belong to the inner and outer membranes, and some interact with both membranes. 
This trans-envelope organisation requires additional assembly processes. For example, the 
movement to and assembly of the secretin in the outer membrane, the establishment of contact 
between the inner membrane components and the secretin, the growth of the pseudopilus from 
the inner membrane to the secretin in the outer membrane, and the integration of the entire 
apparatus with the peptidoglycan net that encircles the cell and resides within the periplasm. 
 
1.9 Auxiliary Components 
Pilotins 
In many cases, the assembly of secretins in the outer membrane is partly directed in some 
species by pilotin proteins (Rehman S., et al. 2013). These small outer-membrane lipoproteins, 
assist their cognate secretins in targeting to the outer membrane or in formation / stabilisation 
of the secretin multimers (Hardi K. R., et al. 1999). The C-terminal region in the T2SS and 
T3SS secretins interacts with their corresponding T2SS and T3SS pilotins, shown as the S-
domain in Figure 4a. 
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Interaction between the secretin GspD and its lipoprotein pilotin is essential of translocation of 
the secretin to the outer membrane in serval species including Klebsiella oxytoca and Dickeya 
dadantii. The pilotins function by directly binding to the unstructured C-terminus of cognate 
secretins (Rehman et al., 2013).  Two structurally dissimilar (unrelated) families of pilotins 
have been identified in various T2SSs. The structure of the paradigm pilotins from OutS/PulS 
family, also called GspSα, comprise an arrangement of four α-helices, while recently identified 
pilotin AspS of GspSβ family is folded in an α/β domain (Gu et al., 2012b; Dunstan et al., 
2013).   
GspA  
In addition, Erwinia, Aeromonas, Vibrio and some other genera possess two other auxiliary 
T2SS components, GspA and GspB, necessary for the correct assembly of their appropriate 
secretin multimers in the outer membrane (Strozen et al., 2011).  GspA possesses a cytoplasmic 
ATPase domain followed by a transmembrane segment and a large periplasmic region that 
contains domain A1 of unknown function and a peptidoglycan-binding domain (Li & Howard, 
2010).  The peptidoglycan-binding domain of GspA belongs to the Pfam family PF01471 and 
is composed of three α-helices (Martynowski et al., 2013).  In Aeromonas and Vibrio, GspA 
and GspB interact together and form an inner-membrane complex that binds peptidoglycan and 
is necessary for the assembly of the secretin (Li & Howard, 2010).  In some other bacteria, 
such as Dickeya, Klebsiella and Pectobacterium, only the GspB component is present whilst 
GspA is apparently lacking.  In this case, the gspB gene neighbours that of the pilotin gspS, but 
the two genes are transcribed independently.  
 
GspB 
Regardless of the presence or absence of a cognate GspA component, all the GspB proteins 
share a common composition. GspB is comprised of a short cytoplasmic region, a single 
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transmembrane segment and a large periplasmic region (Condemine & Shevchik, 2000). OutB 
is a component of the Dickeya dadantii (previously Erwinia chrysanthemi) Out secretion 
machinery. Homologues of OutB have been described in two other bacteria, Klebsiella oxytoca 
and Aeromonas hydrophila, but their requirement in the secretion process seems to be different. 
Study of OutB topology with the BlaM topology probe suggests that it is an inner-membrane 
protein with a large periplasmic domain. However, fractionation experiments indicate that it 
could be associated with the outer membrane through its C-terminal part.  
The secretion deficiency of an D. dadantii outB mutant can be reversed by the addition of an 
inducer of the kdgR regulon. It was shown that this effect results from the increased expression 
of the secretin OutD and that secretion can be restored in an outB mutant by introducing the 
outD gene on a plasmid and overexpressing OutD protein. Several experiments suggest an 
interaction between OutB and OutD. In D. dadantii, the presence of OutD stabilizes OutB. 
OutD expressed in Escherichia coli can be protected from proteolytic degradation by the co-
expression of OutB. This effect does not require the N-terminal, transmembrane segment of 
outB. OutB can be cross-linked with OutD by formaldehyde. These results indicate that OutB 
could act with OutD in the functioning of the Out secretion machinery. 
A recent study in Aeromonas hydrophila suggested that GspB interacts with the periplasmic 
region of the secretin (Vanderlinde et al. 2014). However, the precise function of GspB remains 
to be elucidated. Furthermore, no structural data are available for GspB and there has been no 
clear structural homologue from sequence searches. 
1.10 Aims and objectives of this study 
The aims of this study are to determine the molecular structure of the inner membrane protein 
GspB homologue OutB from Dickeya dadantii and determine the atomic details of its possible 
interaction with the outer membrane secretin OutD. This will hopefuly illuminate important 
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details in the assembly of the secretin multimers and the Type 2 Secretion System in general, 
providing insights in to how this system can be targeted in bacteria which possess homologues 
systems and are pathogenic to human. 
In this thesis, it was possible to address these aims by exploring crystallization of the 
periplasmic domain of OutB from a number of constructs and solving the crystal structure.  
This work is described in Chapter 3. The interaction between OutB and the secretin OutD was 
explored using cross-linking studies and NMR, which are discussed in Chapter 4 and 5, 
respectively. 
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2.1 Molecular biology 
2.1.1 Cloning of OutB  
DNA encoding the C-terminal region (the periplasmic domain) of D. dadantii GspB, residues 
112 to 220, was amplified from the then Erwinia chrysanthemi strain 3557 using suitable 
primers and then subcloned into the pGEM-T Easy (Promega) vector. This allowed for easy 
amplification of the cloned gene so that it could be sequenced and exact sequence confirmed.  
The insert was then subsequently cloned into the expression vector pGEX-6P-3 (G E 
Healthcare; Appendix A1). This plasmid encodes a Glutathione S-transferase (GST) affinity 
tag at the N-terminal which is cleavable at the amino acid sequence LEVLFN|GP by the 
patented PreScission™ protease (GE Healthcare).  
 
2.1.2 Cloning OutD  
Sequence alignment of GspDOutD against GspD from different bacteria shows that the N-
terminal portion of its periplasmic region contains the 3 N-terminal domains possessed by 
many secretins termed N0, N1, N2, and N3. DNA encoding the highly conserved region of 
the periplasmic N0 domain of D. dadantii GspDOutD-N0, residues 28 to 112, was subcloned 
into the pGEM-T Easy (Promega) vector, its sequence confirmed, and then the insert cloned 
into the pET-14b vector (Appendix A2) encoding a cleavable C-terminal hexahistidine tag for 
purification with nickel ion affinity chromatography. This vector is also under the control of 
the LacI operon and inducible by the addition of IPTG. 
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2.1.3 pET14b Vector (Novagen) 
The pET expression system (Novagen) is a system developed for the cloning and expression 
of recombinant proteins in E. coli. Target genes are cloned into pET plasmids under control of 
strong bacteriophage T7 transcription. Expression is induced by providing a source of T7 RNA 
polymerase in the host cell. T7 RNA polymerase is so selective and active that, when fully 
induced, almost all of the cell’s resources are converted to target gene expression (Novagen 
pET System Manual). The desired product can comprise more than 50% of the total cell protein 
a few hours after induction.  
 
It is also possible to attenuate expression levels simply by lowering the concentration of 
inducer. Decreasing the expression level may enhance the soluble yield of some target proteins. 
Another important benefit of this system is its ability to maintain target genes transcriptionally 
silent in the un-induced state. Target genes are initially cloned using hosts that do not contain 
the T7 RNA polymerase gene, thus eliminating plasmid instability due to the production of 
proteins potentially toxic to the host cell.   
 
Once established in a non-expression host, target protein expression is initiated by expression 
by the host of a chromosomal copy of the T7 RNA polymerase gene under lacUV5 control; 
which expression is induced by the addition of IPTG to the bacterial culture. The pET14b 
plasmid specifically encodes an N-terminal hexahistidine tag, with a thrombin cleavage site 
between the His-tag and the target protein of interest. 
 
2.1.4 pGEX-6P-3 Vector (G. E. Healthcare) 
The pGEX vectors are designed for inducible, high-level intracellular expression of genes or 
gene fragments as fusions with Schistosoma japonicum GST. Expression in E. coli yields 
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tagged proteins with the GST moiety at the amino terminus and the protein of interest at the 
carboxyl terminus. 
 
GST occurs naturally as a 26 kDa protein that can be expressed in E. coli with full enzymatic 
activity. Tagged proteins that possess the complete amino acid sequence of GST also 
demonstrate GST enzymatic activity and can undergo dimerization similar to that observed in 
nature. The crystal structure of recombinant S. japonicum GST from pGEX vectors has been 
determined and matches that of the native protein.  
 
Purification of GST-tagged proteins is based on the affinity of GST to the glutathione ligand 
imobilised to a matrix. The binding of a GST-tagged protein to glutathione is reversible, and 
the protein can be eluted under mild conditions by the addition of reduced glutathione to the 
elution buffer. This provides a mild purification process that does not affect a protein’s native 
structure and function. 
 
Cleavage of the protein from the GST tag can be achieved using a site-specific protease 
whose recognition sequence is located immediately upstream from the multiple cloning 
site (MCS) of pGEX plasmids. Tagged proteins can be detected using colorimetric or 
immunological methods. PreScission Protease is a fusion protein of glutathione S-transferase 
(GST) and human rhinovirus (HRV) type 14 3C protease (Walker et al. 1994). The protease 
specifically recognizes a subset of sequences which include the core amino acid sequence Leu-
Phe-Gln/Gly-Pro cleaving between the Gln and Gly residues. Substrate recognition and 
cleavage are likely to be dependent on primary structural signals as well as the secondary and 
tertiary structures of the fusion protein. Since the protease is fused to GST, it is easily removed 
from cleavage reactions using Glutathione Sepharose™ 4B. 
Chapter 2: Methodological Introduction 
 
39 
 
 
Fusion proteins produced from pGEX-6P-1, pGEX-6P-2 and pGEX-6P-3 are cleaved by 
PreScission Protease between the GST moiety and the cloned fusion partner. The molecular 
weight of PreScission Protease is approximately 46 kDa. 
 
2.1.5 Mutagenesis 
Mutagenesis was performed to: 
1. Introduce premature stop codons and from C-terminally truncated mutants. 
2. Perform point mutations to introduce cysteine residues at positions where proteins were 
believed to be interacting and thereby trap the complex using disulphide bond formation. 
In both cases, this was achieved using the Quick Change Lightening II Mutagenesis kit 
(Agilent) with primers designed accordingly (See Appendix B). Mutant DNA was transformed 
in to XL10 ultra competent cells (Agilent) and plasmid DNA extracted by MiniPrep (Qiagen). 
This was then sequenced (MWG Eurofins) to check incorporation of the stop codon generated 
via point mutation. 
The rapid, simple, three-step method is outlined in Figure 2.1. A single mutagenic 
oligonucleotide is required to generate a single mutagenic site, using a double-stranded, non-
mutated DNA template. A complimentary oligonucleotide incorporating the point mutation 
and with a GC content >45% must first be synthesized. Temperature cycling then allows for 
melting of the double stranded template, cooling to allow annealing of the mutagenic primer, 
and then an extension/synthesis period whereby the mutagenic primer is incorporated into a 
new plasmid. 
DpnI, a type II M restriction endonuclease, is then used to recognize and cut exclusively the 
template, methylated DNA. Resulting in only newly synthesized, mutagenic plasmids. This 
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process allows for mutagenesis to be performed in approximately two hours, plus an overnight 
transformation of the newly generated DNA construct. 
 
 
 
Figure 2.1 Cartoon and description of the Quick Change Lightning II™ protocol to 
generate mutations in plasmid DNA 
 
 
 
 
 
1.  Thermal cycling 
 Denatures DNA template 
 Allows mutagenic primer to anneal 
 Extend primers and ligate nicks 
with pfu fusion enzyme blend. 
2. DpnI digestion of the template 
 DpnI exclusive digests methylated 
and hemimethylated DNA 
3. Transform mutated ssDNA into  
 XL10 Gold ultracompetent cells.  
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2.1.6 Production and Purification of target proteins   
Expression constructs were transformed in to E. coli strain BL21(DE3) (Bioline), for protein 
expression. This strain of competent cells was used in expression of all protein constructs and 
contains the T7 polymerase gene under the control of the LacUV5 promoter. Addition of IPTG 
(isopropyl-β-D-thiogalactopyranoside) induces constitutive expression of T7 polymerase. For 
Expression vectors under the control of a T7 promoter (pGEX and pET used in this work), the 
polymerase transcribes the T7 polymerase mRNA at a high copy number resulting in over-
expression of the desired protein.  
 
2.2 Biochemistry 
2.2.1 SDS PAGE Gel 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), allows proteins to 
be separated and visualised according to their electrophoretic mobility, a function of the length 
of a polypeptide chain (proportional to its mass) and its charge. This can be used in a qualitative 
way to assess the expression and purification of proteins. 
According to the size range of the proteins to be resolved, 12% and 18% polyacrylamide gels 
were used. These were prepared according to standard molecular biology protocols. Self-cast 
gels were made, adding TEMED just before pouring the gel mixture into the Bio-Rad gel cast 
(Bio-Rad). The resolving gel was poured into the cast first, followed by the stacking gel. A 
comb for 10 or 15 wells was inserted, before the gel was left to set. 
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2.2.2 UV/Vis 
Protein concentration was determined directly by spectroscopic analysis using UV-Vis 
spectrophotometer (HITACHI U-3010). Protein absorbance at 280nm was measured. 
Concentration was determined according to: 
Equation 2.1   A280= ε . c . l 
Where c is the molar concentration, A280 is the absorbance at 280nm, ε is the molar extinction 
coefficient, typically calculated using the ExPASy ProtParam webserver 
(http://web.expasy.org/protparam/)  and l is the path-length of the cuvette.  
The absorbance ratio of A260/A280 was measured to check DNA contaminations. An 
A260/A280 ratio below 0.7 was considered to have no DNA contamination. 
 
2.2.3 Circular Dichroism 
Circular Dichroism (CD) is an excellent method to give an indication of the secondary structure 
of the protein. Although it is not possible to give detailed residue-specific information as 
obtainable from NMR and crystallography, it can provide secondary structure information 
using only small amounts of protein and it is extremely sensitive to changes in secondary 
structure and can also be used to monitor the conformational changes, for instance as a function 
of temperature, pH, or ionic strength (Martin et al 2008).  
CD measures the difference in the absorption of right (AR) and left circular polarised light (AL). 
Therefore, for a sample to be CD active it must be chiral. Amino acids are optically active as 
they contain α-carbons with four different groups attached. The chiral character of a sample 
allows for the differential absorption of the L- and R- circularly polarised light (ΔA), this will 
produce a CD spectrum. The difference in absorption can be related to the molar extinction 
coefficient using the Beer-Lambert’s law (Equation 2.2) 
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Equation 2.2  ∆𝜀 =  𝜀𝐿 −  𝜀𝑅 =  
(𝐴𝐿− 𝐴𝑅)
𝑐.𝑙
=  
∆𝐴
𝑐.𝑙
 
Where Δε is the difference in molar extinction coefficient, ΔA is the difference in absorbance 
(AL - AR), c is the molar concentration and l is the path-length of the sample in centimetres. 
 
The relationship between the direct CD measurements (in millidegrees), θ, and Δε, M-1cm-1, is 
highlighted in equation 2.3 below. Please note that the relationship between CD measurement 
and change in absorbance is θ = ΔA . 33,000. 
Equation 2.3 ∆𝜀 =  
𝜃
33,000.𝑐.𝑙
 
Where θ is the direct CD measurement in millidegrees, c is the molar concentration and l is the 
path-length of the cuvette in centimetres. 
 
The far-UV region spans wavelengths 170 to 250 nm, this region is essential for measuring 
secondary structural changes of a protein. Far-UV-CD uses the two electronic absorptions of 
the backbone amide group, the electronic dipole from the π – π* transition at 190 nm and the 
magnetic dipole from the weaker n - π* transition at 210 nm. These transitions dominate the 
CD spectrum to produce a trace characteristic of the ψ (psi) and φ (phi) torsion angles, 
therefore, are characteristic of secondary structure of the polypeptide chain. Different structural 
conformation produce characteristic CD spectrum, as shown in Figure 2.2. Due to the versatile 
nature of far-UV-CD it has been as a valuable technique for thermal denaturation studies. 
Visible Region. This region of the CD spectrum is useful for monitoring metal – ligand binding 
and it makes use of the wavelengths from 300 to 800 nm. The visible region monitors the 
difference in the charge transfer, metal, d – d, and ligand, p – p*, transitions. As with far-UV-
CD, a trace is only observable if a metal is bound to a ligand in a chiral environment. Therefore, 
free metal ions, even with d – d transitions, are CD silent. 
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Figure 2.2 Typical CD Traces for secondary structure elements 
This far-UV-CD illustration demonstrates the different structural conformations (such as α-
helix, β-sheet, polyproline II and irregular structure) and the characteristic traces that are 
produced. This figure has been adapted from S. Brahms et al. (Brahms, S., et al. 1980). 
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2.2.4 Dynamic Light Scattering 
Dynamic Light Scattering (DLS), also known as Photon Correlation Spectroscopy (PCS) and 
Quasi-elastic Light Scattering (QELS), is a technique used to determine the size distribution 
profile of small particles in suspension. In DLS, a laser beam is directed into a solution and, 
the light energy is scattered when it meets a particle. The scattered light is detected on a photon 
detector connected to a correlator.  
The scattered light is a function of the hydrodynamic size and the concentration of the sample. 
Higher concentrations of molecules scatter more light than lower concentrations. Similarly 
larger molecules scatter more light than smaller molecules at the same concentration.  
Time-dependent fluctuations in the scattered light occur because the particles are moving under 
Brownian motion; these fluctuations are directly related to the rate of diffusion of the molecules 
in the solution. The correlator compares the intensity of the scattered light at time t with that at 
time t+δt, t+2δt, t+3δt, etc, and thus generates a correlation function. Since small molecules 
diffuse faster, they lead to a faster decay in the measured correlation function. The measured 
decay rate is thus related to the hydrodynamic size of the scattering object. 
In dynamic light scattering, the speed at which the particles are diffusing due to Brownian 
motion is measured. This is done by measuring the rate at which the intensity of the scattered 
light fluctuates when detected using a suitable optical arrangement. The rate of the scattering 
intensity fluctuation occurring depends on the size of particles. The small particles cause the 
intensity to fluctuate more rapidly than the large ones. The size of a particle is calculated from 
diffusion coefficient using the Stokes-Einstein equation (Equation 2.4). 
Equation 2.4   𝐃 =  
kBT
6πηR
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2.2.5 Mass Spectrometry 
The most relevant form of mass spectrometry as applied to macromolecules, particularly 
proteins, is electrospray ionization (ESI). This technique, first reported by Masamichi 
Yamashita and John Fenn in 1984 (Yamashita & Fenn, 1984) is used in mass spectrometry to 
produce ions using an electrospray in which a high voltage is applied to a liquid to create an 
aerosol.  
It is especially useful in producing ions from macromolecules as it overcomes the tendency of 
these molecules to fragment when ionized. ESI is different from other atmospheric pressure 
ionization processes (e.g. MALDI) since it may produce multiply charged ions, effectively 
extending the mass range of the analyser to accommodate the kDa-MDa orders of magnitude 
observed in proteins and their associated polypeptide fragments (Ho et al. 2003). 
Mass spectrometry using ESI is called electrospray ionization mass spectrometry (ESI-MS) or 
electrospray mass spectrometry (ES-MS). ESI is a 'soft ionization' technique as very little 
fragmentation occurs. This is advantageous as a molecular parent ion (or more accurately a 
pseudo molecular ion) is always observed, however very little structural information can be 
gained from the simple mass spectrum obtained. This disadvantage can be overcome by 
coupling ESI with tandem mass spectrometry (ESI-MS/MS).  
Electrospray ionization is the preferred technique to couple liquid chromatography with mass 
spectrometry. The analysis can be performed sequentially by feeding the liquid eluting from 
the liquid chromatography column directly to an ESI-MS setup. 
The detection of ions is performed by a quadrupole mass spectrometer, sometimes referred to 
by the Agilent trade name "Mass Selective Detector" (MSD) 
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2.3 Crystallography 
2.3.1 Theory 
X-ray crystallography is the most powerful method to gain atomic resolution structures of 
biological molecules. The process involves purifying, crystallising and then collecting 
diffraction data from the crystal of the biological macromolecule in question.  Electrons scatter 
X-rays to produce a continuous diffraction pattern of X-ray amplitude and phase.  In a crystal, 
the diffracting electron density is convoluted with the lattice function, and consequently the 
pattern of diffracted X-rays is the product of the lattice transform, which itself is a lattice, the 
‘reciprocal lattice’, and the transform of the density, which is consequently only sampled at 
discrete lattice points, defined by the integers h, k and l.  The Fourier transform, equation 2.5, 
relates the electron density of a crystal structure and its diffraction pattern in reciprocal space 
as follows: 
Equation 2.5 
ρ (x,y,z) = Σ Σ Σ F (hkl) exp {-2πi (hx + ky +lz) }                   
                                          h k l 
 
Where ρ(x,y,z) is the electron density and F(hkl) are the Fourier coefficients of the structure.  
F (hkl) is a complex quantity comprising a measurable amplitude, F (hkl), and non-directly 
observable phase, α (hkl).   
 
The phases of the reflections are obtained, either experimentally or using molecular 
replacement methods to estimate the phase angles. Once information on the phase of the 
diffracted X-rays is available, the Fourier transform (Equation 2.1 above) can be used to 
construct the electron density in reciprocal space.   A model of the protein molecule can then 
be built into the electron density using various geometric and other restraints from small 
molecule crystallography. 
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When X-rays are diffracted by a crystal they obey Bragg's law which is explained thus: Two 
beams with identical wavelength and phase approach a crystalline solid and are scattered off 
two different atoms within it. The lower beam (Figure 2.3.1) traverses an extra length of 2dsinθ. 
Constructive interference occurs when this length is equal to an integer multiple of the 
wavelength of the radiation giving equation 2.6. 
 
 
 
 
 
 
 
 
Figure 2.3.1 Explanation of Bragg Diffraction Crystalline particles within a lattice are shown 
as dots, equivalent planes within the crystal as horizontal thicker lines and incoming radiation 
as thin lines. The spacing, d is equal to the wavelength of the incoming radiation. 
 
Equation 2.6 nλ = 2dsinθ 
Where n is an integer, λ is the wavelength of incident X-ray radiation, d the spacing of 
interatomic planes and θ the angle of reflection.  
 
2.3.2 Molecular Replacement and Structure Solution 
The Molecular Replacement method is used to derive phase information from a partially-
known existing model of the structure. Molecular Replacement (MR) also provides an initial 
starting model for refinement. Since there are an ever-increasing number of structures available 
in the PDB database, the chances are getting more and more reasonable that there will be at 
least a partial model available for your structure. 
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The first step in solving the phase problem by molecular replacement is to identify a suitable 
structure to use as a search model, this is usually via a blast search of the protein sequence 
against those of known protein structures.  The method then involves finding the rotation and 
subsequently the translation that relates the search model to the unknown structure.  Patterson 
superimposition methods are typically used in these calculations.  The Patterson function, 
P(uvw), is calculated in the same way as electron density (equation 2.1) , but the structure 
factor amplitude is squared, F(hkl) 2, and the phase, α (hkl), is set to zero. The self-vectors 
needed for establishing the rotational relationship all lie in a volume around the origin of the 
Patterson function within a radius equal to the dimension of the molecule.  For the rotation 
function the Patterson function calculated from the known structure can be rotated on to the 
Patterson function calculated from the experimental data with the maximum overlap giving the 
rotation matrix relating the known to the unknown structure.  The translation function is then 
used to look for a correlation between cross-vectors of the Patterson function and therefore 
yield the position of the rotated search model in the unknown cell. 
 
Phaser (McCoy, 2007) is an automated molecular replacement software package that combines 
anisotropy correction, likelihood enhanced fast rotation function, likelihood enhanced fast 
translation function, packing and refinement modes for multiple search models and allows a 
set of possible spacegroups to be searched in order to automatically solve a structure by 
molecular replacement. 
 
However, if the correlation between search model and the actual protein structure in the crystal 
is low, the log likelihood gain (LLG) signal-to-noise of the search will below, there will be 
noise peaks and multiple ambiguous solutions. Signal-to-noise is judged using the Z-score, 
which is computed by comparing the LLG values from the rotation or translation search with 
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LLG values for a set of random rotations or translations. The mean and the RMS deviation 
from the mean are computed from the random set, then the Z-score for a search peak is defined 
as its LLG minus the mean, all divided by the RMS deviation, i.e. the number of standard 
deviations above (or below) the mean. 
 
For a translation function the correct solution will generally have a Z-score (number of standard 
deviations above the mean value) over 5 and be well separated from the rest of the solutions. 
Table 2.1 gives a very rough guide to interpreting TF Z-scores.  
 
TF Z-score Have I solved it? 
less than 5 no 
5 - 6 unlikely 
6 - 7 possibly 
7 - 8 probably 
more than 8* definitely 
Table 2.1 Explanation of TF Z-scores given by Phaser MR program 
2.3.3 Model Building 
Model building can be automatic using PHENIX (Adams et al. 2010) or ARPWARP (Langer 
et al. 2008) but sometimes manual intervention is needed to build poorer regions of the 
electron density map using graphics programs such as COOT (Emsle. et al., 2010). 
2.3.4 Structure refinement 
Refinement is the optimization of the fit of the molecular model to the diffraction data. 
Maximum likelihood methods are employed in programs such as REFMAC (Winn et al., 2003) 
which adjusts the atomic positions and temperature factors to obtain a model that best accounts 
for the experimental data (maximizes the likelihood).  Progress is measured by the fall in R-
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factor and R-free, as well as by the likelihood scores.  In reality, when optimizing a model at 
medium resolution such as 2.0–3.0 Å, cycles of refinement followed by manual rebuilding are 
used until a good agreement is seen between electron density map and model and the refined 
residuals and stereochemical quality indicators, such as deviation in bond lengths, are adequate. 
2.3.5 Validation and deposition 
Structures are validated against observations not included in the refinement process, such as 
agreement of main-chain torsion angles with allowed regions of the Ramachandran plot or of 
side-chains rotomers with accepted rotomer distributions.  Programs such as PROCHECK 
(Laskowski et al., 1993) or MolProbity are used to validate structures and protein databank 
deposition imposes a reasonable stringency in checking the deposited structure. 
 
2.3.6 Crystalisation  
Crystallization conditions were screened using hanging drop vapour diffusion. Crystalisation 
as a process first involves the nucleation of molecules in a saturated solution (Figure 2.3). 
Initially this requires the protein to be undersaturated and soluble. Then, as the precipitant 
reservoir draws water from the protein drop, the concentration of protein increases allowing 
nucleation and the growth of a crystal. However, if crystals begin to grow, the concentration 
of protein in solution will decrease. 
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Figure 2.3.2 Top: Depiction of concentration changes necessary for crystal growth As 
solvent in the hanging drop evapourates, the concentration of protein in the drop increases, 
causing the solution to go from undersaturated to a concentration where nucleation can occur. 
As protein forms nuclei, the concentration in solution decreases allowing metastable crystal 
growth. 
Bottom: Cartoon of Hanging Drop Set up A cartoon showing a typical set-up for hanging 
drop. Curly arrow shows net movement of water and dehydration of protein drop. 
 
 
Hanging 
protein drop 
Precipitant 
reservoir 
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Crystallisation conditions were screened using hanging drop vapour diffusion (Figure 2.3.2) in 
96 well plates wherein protein and precipitant drops were in the range of 200-400nL. These 
were set up set up using a nanodrop Mosquito liquid handling robot (TTP Labtech).  
Sparse matrix screens such as JCSG+ / PACT Premier (Molecular Dimensions) were used to 
trial as many different conditions of pH, ionic strength and precipitating agent as possible.  
2.3.7 Crystalisation optimisation 
However, scaling up, to 1-2µL drops in 24 well plates to make crystal handling easier proved 
unsuccessful by vapour diffusion alone. Further crystals were however successfully obtained 
by whisker streak seeding, using the initial hit as a source of seeds.  Selected crystals were 
removed from the mother liquor and transferred to a solution containing mother liquor plus 5% 
propane-1,2-diol as a cryoprotectant and flash cooled in liquid nitrogen. 
 
2.4 NMR spectroscopy 
2.4.1  Theory 
Both X-ray crystallography and Nuclear Magnetic Resonance (NMR) spectroscopy have their 
limitations and advantages. Protein NMR is limited by the size of the protein as data is collected 
about individual atoms with very similar, but subtly different properties, the major difficulty 
become assigning which chemicals shifts correspond to which atoms in the protein, and as the 
size of the protein increase so does the number of atoms and the difficulty is confounded. NMR 
is very sensitive to the chemical environment of individual atoms and as such is a powerful 
method to explore protein/ligand interactions and protein dynamics. 
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The phenomenon of NMR arises because subatomic particles (electrons, protons and neutrons) 
can be imagined as spinning on their axes. In many atoms (such as 12C) these spins are paired 
against each other, such that the nucleus of the atom has no overall spin. However, in atoms 
with an odd number of neutrons and/or protons the nucleus does possess an overall spin. For 
example, in atoms such as 1H and 13C which both have I= ½ spin states 
A nucleus with spin 1/2 will have 2 possible orientations. In the absence of an external magnetic 
field, these orientations are of equal energy. If a magnetic field is applied, then the energy 
levels split. Each level is given a magnetic quantum number, m.  
 
 
 
 
 
Figure 2.4 Energy levels for a nucleus with spin quantum number I=½  A diagram 
depicting the 2 possible energy states of an I=1/2 nucleus under an applied magnetic field. 
Lower energy state when aligned with and higher when aligned against an applied magnetic 
field (B0) 
The most common natural occurring isotopes of the atoms most relevant to biomolecules (12C, 
14N) have I=0 and as a result are ‘NMR silent’. However, it is possible to produce proteins 
containing isotopes which do provide NMR signals (13C, 15N) and this process requires 
labelling protein. IN essence this is a straight forward process and involves producing the 
protein recombinantly and growing the protein producing organism in a broth / environment 
supplemented with glucose and nitrogen containing this heavier isotopes. 
Chapter 2: Methodological Introduction 
 
55 
 
15N singly or 13C- and15N-doubly isotopically labeled protein were used to record various 
spectra. Protein used to record 3D experiments was around 0.5mM. Sample concentrations 
ranging from 25μM to 0.5mM were used to record 2D spectra depending 
on the nature of the experiment and the time available. 
 
2.4.2 Spectra 
1H-15N HSQC 
1H-15N Heteronuclear Single Quantum Coherence (HSQC) spectra and 1H-15N Sofast- 
HMQC were used for purposes such as sample evaluation, thermal melt analysis, 
titration experiments and for assignment. 
 
 
 
 
 
 
 
Figure 2.5 Diagram depicting the magnetisation transfer in a typical 1H-15N HSQC 
experiment. 
 
In an HSQC experiment, magnetization is transferred from hydrogens to attached to 15N nuclei 
via J-coupling (Figure 2.5). The chemical shift is evolved on the nitrogen and the magnetisation 
is then transferred back to the hydrogen for detection. This shows all H-N correlations.  
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These amides are predominantly the backbone amide groups, but Trp side-chain Nε-Hε groups 
and Asn/Gln side-chain Nδ-Hδ2/Nε-Hε2 groups are also visible. The Arg Nε-Hε peaks are in 
principle also visible, but because the Nε chemical shift is outside the region usually recorded, 
the peaks are folded/aliased (this essentially means that they appear as negative peaks and the 
Nε chemical shift has to be specially calculated). If working at low pH the Arg Nη-Hη and Lys 
Nζ-Hζ groups can also be visible, but are also folded/aliased. 
 
The spectrum is rather often termed the “fingerprint” of a protein as it is highly individual to a 
particular protein. It was the first heteronuclear experiment performed and used to assess 
whether the protein was folded In solution and whether further NMR experiments were likely 
to succeed. 
HNCACB  
 
 
 
 
 
 
Figure 2.6 Diagram depicting the magnetisation transfer in a typical HNCACB 
experiment. 
 
Magnetisation is transferred from Hα and Hβ to Cα and Cβ, respectively, and then from Cβ to 
Cα. From here it is transferred first to NH and then to HN for detection. Transfer form Cαi-1 
can occur both to Ni-1 and Ni, or viewed the other way, magnetisation is transferred to Ni from 
both Cαi and Cαi-1. Thus for each NH group there are two Cα and Cβ peaks visible. The 
chemical shift is evolved simultaneously on Cα and Cβ, so these appear in one dimension. The 
chemical shifts evolved in the other two dimensions are 15NH and 1HN. 
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CBCA(co)NH  
 
 
 
 
 
Figure 2.7 Diagram depicting the magnetisation transfer in a typical CBCA(co)NH 
experiment. 
 
In recording a CBCA(co)NH spectrum, magnetisation is transferred from Hα and Hβ to Cα and 
Cβ, respectively, and then from Cβ to Cα. From here it is transferred first to CO, then to NH 
and then to HN for detection (Figure 2.7). The chemical shift is evolved simultaneously on Cα 
and Cβ, so these appear in one dimension. The chemical shifts evolved in the other two 
dimensions are NH and HN. The chemical shift is not evolved on CO. 
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Nuclear Overhauser Effect (NOE)  
The Nuclear Overhauser Effect (NOE) is a phenomenon observed by cross relaxation between 
dipolar coupled spin systems (Figure 2.8). It is exceptionally important tool for structural 
studies. 
 
 
 
 
 
Figure 2.8 Diagram depicting the magnetisation transfer in a typical CBCA(co)NH 
experiment. 
 
2.4.3 NMR titration 
NMR titration is achieved by recording a 1H-15N HSQC/ 1H-15N Sofast-HMQC spectra 
of the labeled protein. Cross titrations were performed to eliminate the dilution of the labeled 
protein. In cross titration, two samples were prepared; one sample was labeled protein only and 
the second sample had the same concentration of labeled protein and a high equivalent (i.e. 10 
equivalents) of unlabeled titration partner. During the titraion the concentration of labeled 
protein did not change, so it was not necessary to correct for dilution. 
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2.5 Protein Structural Simulation and Docking 
The program HADDOCK is a protein-protein docking algorithm which uses biochemical and 
biophysical information to provide a model of the protein-protein complex (Dominguez, 
Boelens et al. 2003). It uses experimental data (i.e. chemical shift perturbation data, site specific 
mutagenesis data). The information on interacting residues is introduced as ambiguous 
interaction restrains (AIRs) to drive the docking.  
In the case of NMR titration data, the active residues correspond to all residues showing a 
significant chemical shift perturbation upon complex formation as well as high solvent 
accessibility in the free form of protein. The passive residues correspond to the residues that 
show a less significant chemical shift perturbation and/or that are surface neighbours of the 
active residues with high solvent accessibility (>50%). The AIRs files are generated by entering 
active and passive residue on http://www.nmr.chem.uu.nl/haddock/. 1000 docking structures 
were generated for each calculation. The output structures are ranked according to their 
intermolecular energy. 
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Chapter 3: Methods & Protocols 
Molecular & Cellular Biology 
 
3.1 LB Media 
LB Media used for growing E. coli was made up using standard protocol (below) and 
made up to 1L and sterilized by autoclaving at 121°C for 15 min.   
 
Component Concentration (g/L) 
Bacto-tryptone (A pancreatic digest of casein) 10 
Yeast extract 5 
Sodium chloride 5 
Table 3.1 Contents of LB media 
   
 
3.2 Minimal (M9) Media - 10x Stock 
Component Concentration (g/L) 
Na2HPO4 60 
KH2PO4 30 
Sodium chloride 5 
Table 3.2 Contents of M9 media 
 
3.3 BL21(DE3) Transformation 
1. Remove cells from –80°C and let thaw on wet ice. 
 
2. Gently mix cells by lightly flicking tube. Aliquot ~50-100µl of cells into chilled, 17 
x 100mm polypropylene tube(s), e.g., Falcon 2059. Unused cells may be refrozen, but 
a small drop in efficiency may result. For optimal recovery, refreeze cells in a dry ice/ 
ethanol bath prior to -80°C storage. 
 
3. Add DNA solution (≤5µl per 50µl cells) to cell suspension and gently swirl tube(s) 
for a few seconds to mix. If a control is desired, repeat this step with 2µl of the 
provided Control Vector (pUC19) in a separate tube. 
 
4. Incubate on ice for 30 minutes. 
 
5. Place tube(s) in 42°C water bath for ~30 to 45 seconds without shaking. 
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6. Replace tube(s) on ice for ~2 minutes. 
 
7. Dilute transformation reaction(s) to 1ml by addition of 900-950µl LB media. 
 
8. Shake tube(s) ~200 rpm for 60 minutes at 37°C. 
 
9. Plate by spreading 5-200µl of cell transformation mixture on LB agar plates 
containing appropriate antibiotic and incubate overnight at 37°C. 
 
3.4 Mutagenesis – Stratagene Quickchange Protocol 
a) Mutant Strand Synthesis Reaction (Thermal Cycling) 
1. Prepare the ds-DNA template either by standard miniprep protocols (e.g. StrataPrep 
Plasmid Miniprep Kit, catalog #400761) or by cesium chloride gradient purification.  
2. Prepare the mutant strand synthesis reactions for thermal cycling as indicated 
below. Add the components in the order listed then mix gently by pipetting or tapping 
the reaction tube. 
Reaction Component Templates <5kb Templates >5kb 
10x QuickChange 
Lightning Multi reaction 
buffer 
2.5 µL 2.5 µL 
Double distilled H2O To final volume of 25 
µL 
To final volume of 25 
µL 
ds-DNA template 50 ng 100 ng 
Mutageneic primers 100 ng each primer for 
1-3 primers; 50 ng each 
primer for 4-5 primers 
100 ng each primer for 
1-3 primers; 50 ng each 
primer for 4-5 primers 
dNTP Mix 1 µL 1 µL 
QuickChange Lightning 
Multi enzyme blend 
1 µL 1 µL 
Table 3.3 Reaction components for Quick Change Lightening II mutagenesis reactions 
3. Cycle the reactions using the cycling parameters outlined in the table below. (For 
the control reaction, use a 2.5-minute extension time.) 
4. Following temperature cycling, place the reaction on ice for 2 minutes to cool the 
reaction to ≤37°C. 
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b) Dpn I Digestion of the Amplification Products  
1. Add 1 µl of Dpn I restriction enzyme directly to each amplification reaction.  
2. Gently and thoroughly mix each reaction mixture by pipetting the solution up and 
down several times. Spin down the reaction mixtures in a microcentrifuge for 1 
minute, then immediately incubate each reaction at 37°C for 5 minutes to digest the 
parental (nonmutated) ds-DNA.  
c) Transformation of XL10-Gold Ultracompetent cells 
1. Gently thaw the XL10-Gold ultracompetent cells on ice. For each mutagenesis 
reaction, aliquot 45 µl of the ultracompetent cells to a prechilled 14-ml BD Falcon 
polypropylene round-bottom tube.  
2. Add 2 µl of the β-ME mix provided with the kit to the 45 µl of cells. Using an 
alternative source of β-ME may reduce transformation efficiency.  
3. Swirl the contents of the tube gently. Incubate the cells on ice for 10 minutes, 
swirling gently every 2 minutes. 
4. Transfer 1.5 µl of the Dpn I-treated DNA from each mutagenesis reaction to a 
separate aliquot of the ultracompetent cells. Optional Verify the transformation 
efficiency of the XL10-Gold ultracompetent cells by adding 1 µl of 0.01 ng/µl pUC18 
control plasmid (dilute the provided pUC18 DNA 1:10) to another 45-µl aliquot of 
cells.  
5. Swirl the transformation reactions gently to mix, then incubate the reactions on ice 
for 30 minutes.  
6. Preheat NZY+ broth (see Preparation of Media and Reagents) in a 42°C water bath 
for use in step 9. Note Transformation of XL10-Gold ultracompetent cells has been 
optimized using NZY+ broth.  
7. Heat-pulse the tubes in a 42°C water bath for 30 seconds. The duration of the heat 
pulse is critical for obtaining the highest efficiencies. Do not exceed 42°C. Note This 
heat pulse has been optimized for transformation in 14-ml BD Falcon polypropylene 
round-bottom tubes.  
8. Incubate the tubes on ice for 2 minutes.  
9. Add 0.5 ml of preheated (42°C) NZY+ broth to each tube and incubate the tubes at 
37°C for 1 hour with shaking at 225–250 rpm.  
10. Plate 100 µL of each transformation reaction, on agar plates containing the 
appropriate antibiotic for the plasmid vector. For the mutagenesis and transformation 
controls, spread cells on LB–ampicillin agar plates (see Preparation of Media and 
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Reagents) that have been prepared with 80 µg/ml X-gal and 20 mM IPTG (see 
Preparing the Agar Plates for Color Screening). 
 
3.5 Expression of OutB  
After successful transformation, individual colonies were used to inoculate 10ml “starter 
cultures” containing 100µgml-1 ampicillin and were grown at 37°C for 16h, typically overnight. 
These were used to inoculate 1L cultures of LB media. Cells were grown to an OD600 of 0.6–
0.8 and expression induced by addition of 0.2 mM IPTG. Induced protein expression was 
allowed to proceed for 16 h at 20°C typically overnight.  
 
3.6 Expression of GspDOutD N0 
After successful transformation, individual colonies were used to inoculate 10ml “starter 
cultures” containing 100µgml-1 ampicillin. The culture was grown at 37°C and induced with 
1mM IPTG when optical density (OD600) reached 0.6-0.8. Cells culture continued to be 
incubated at 37°C for 4 h post induction. 
 
3.7 GST-Tag Purification of OutB 
Cells from a 1L culture were harvested by centrifugation at 10,000g for 20min then 
resuspended in 20ml of cell culture of phosphate buffered saline (PBS) containing 0.01M 
phosphate buffer, 0.0027M KCl and 0.137M NaCl, pH 7.4. It is possible to store resuspended 
cell pellets at this stage by freezing at -80°C. Subsequent steps can be completed after thawing 
the cell pellet.  
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Cells were lysed on ice by sonication at 20W with 20 replicates of 10s sonication followed by 
20s of cooling..  Cell debris was removed by centrifugation at 35,000g for 20min.Afterwards, 
the supernatant was decanted and incubated with 2.5ml of Glutathione sepharose beads (G.E. 
Healthcare) for 6h. The glutathione sepharose was then collected in a column and washed with 
20 column volumes (50 ml) of PBS. 
On column cleavage of the GST tag required washing Glutathione sepharose with bound GST-
OutB in PreScission  protease (G.E. Healthcare) buffer containing (50mM Tris-HCl, 150 mM 
NaCl, 1 mM EDTA, 1 mM DTT, pH 7.0) and addition of 20µL of PreScission protease to 5ml 
bead volume of glutathione sepharose. Cleavage was at 4°C for 6hr. Elutate containing the tag-
less GspB112-220 was then run on a Superdex S200 gel filtration column and SDS-PAGE used 
to assess and confirm purity prior to crystallisation 
 
3.8 His-tag purification of GspDOutD N0 
GspD was expressed with a C-terminal hexahistidine tagged and purified as follows. Cells were 
collected and the pellet was lysed by sonication as detailed above in a binding buffer 
(20mMTris, 400mM NaCl, 20mM imidazole pH8.0). The soluble protein fraction was then 
separated by centrifugation at 15,000g for 15 mins and applied to the pre-packed His-Trap 
column (GE Healthcare). The column was pre-equilibrated in binding buffer, using a flow rate 
of 1ml/min. The non-specifically binding proteins were eliminated by washing with 20 column 
volumes (CV) of Ni column washing buffer (20mM Tris, 400mM NaCl, 20mM imidazole pH 
6.5) until no more protein was detected in the flow through as determined using Bradford 
solution. 
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The bound, target protein was eluted using elution buffer (20mM Tris, 400mM NaCl, 500mM 
imidazole, pH6.5) again until no further protein was detected in flow through, tested using 
Bradford solution. The eluted fractions were checked using SDS-PAGE. 
 
3.9 Isotope Labelling for NMR 
Recombinant uniformly 15N- 13C- labeled full length OutB (or OutD-N0) was 
expressed using the relevant vector in BL21(DE3) (Novagen),. Starter cultures were grown in 
LB media, and used to innoculate growth in M9 minimal media.  
M9 minimal media supplemented with trace elemnts and isotope sources as listed below. 
All minimal media was 0.2μm filter sterilized.  
Compound Concentration (g/L) 
Na2HPO4 6 
KH2PO4 2 
NaCl 0.5 
MgSO4 0.25 
CaCl2 0.015 
FeSO4 0.015 
Thiamine 0.001 
Biotin 0.001 
15NH4Cl 1 
13C D-glucose 2 
Antibiotic – Ampicillin 0.1 
Table 3.4 Contents of isotopically enriched M9 media with supplementary trace 
elements 
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3.10 SDS PAGE 
SDS-PAGE gels were cast and run using the Bio-Rad mini tank system.  
Thickness (mm) Volume of Stacking Gel 
(ml) 
Volume of Resolving Gel 
(ml) 
0.75 2 4 
1.0 3 6 
1.5 4 8 
Table 3.5 Volumes required for casting gels in Bio-Rad system 
 
Stacking gels are always of a consistent percentage acrylamide content in order to ensure 
movement of the protein mixture into the resolving gel. 
Component Volume (ml) 
H2O 2.975 
0.5 M Tris-HCl, pH 6.8 1.25 
10% (w/v) SDS 0.05 
Acrylamide/Bis-acrylamide 
(30% / 0.8% w/v) 
0.67 
10% (w/v) ammonium persulfate 
(AP) 
0.05 
TEMED 0.005 
Table 3.6 Component volumes for 4ml stacking gel 
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Resolving gels consisted of crosslinked polyacrylamide made up at varying concentrations in 
order to allow resolution of various molecular weight proteins. 
Acylamide percentage 6% 8% 10% 12% 15% 
H2O 5.2ml 4.6ml 3.8ml 3.2ml 2.2ml 
Acrylamide/Bis-acrylamide 2ml 2.6ml 3.4ml 4ml 5ml 
1.5M Tris(pH=8.8) 2.6ml 2.6ml 2.6ml 2.6ml 2.6ml 
10% (w/v)SDS 0.1ml 0.1ml 0.1ml 0.1ml 0.1ml 
10% (w/v) ammonium 
persulfate (AP) 
100μl 100μl 100μl 100μl 100μl 
TEMED 10μl 10μl 10μl 10μl 10μl 
Table 3.7 Component volumes for 5ml stacking gel at various acrylamide 
concentrations  
 
Samples were boiled in a buffer to ensure denaturation of the protein and addition of SDS to 
ensure charge of the protein. DTT or β-ME can be excluded if you wish to run proteins under 
non-reducing conditions (i.e. if disulphide bonds may be present). 
10% w/v SDS 
10 mM 
Dithiothreitol, or 
beta-mercapto-
ethanol 
20 % v/v Glycerol 
0.2 M Tris-HCl, pH 6.8 
0.05% w/v Bromophenolblue 
Table 3.8 5x Sample Buffer composition 
 
1x Running Buffer 
25 mM 
Tris-
HCl 
200 mM Glycine 
0.1% (w/v) SDS 
Table 3.9 Running buffer composition 
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Protocol: 
1. Make the separating gel: 
Set the casting frames (clamp two glass plates in the casting frames) on the casting 
stands. 
Prepare the gel solution (as described above) in a separate small beaker. 
Swirl the solution gently but thoroughly. 
Pipet appropriate amount of separating gel solution (listed above) into the gap 
between the glass plates. 
To make the top of the separating gel be horizontal, fill in water (either isopropanol) 
into the gap until a overflow. 
Wait for 20-30min to let it gelate. 
Make the stacking gel: 
Discard the water and you can see separating gel left. 
Pipet in stacking gel untill a overflow. 
Insert the well-forming comb without trapping air under the teeth. Wait for 20-30min 
to let it gelate. 
2. Make sure the stacking gel is completely set and remove the well comb. Take the glass 
plates out of the casting frame and set them in the running buffer dam. Pour the running 
buffer into the inner chamber and keep pouring after overflow until the buffer surface reaches 
the required level in the outer chamber. 
3. Prepare the samples: 
Mix samples with sample buffer 
Heat (90°C) for 5-10 min. 
4. Load prepared samples into wells and make sure not to overflow. Load protein marker into 
the first lane.  
5. Attach top and connect the anodes. 
5. Set an appropriate voltage and run the electrophoresis. 
Total running time: stop SDS-PAGE running when the bromophenol blue dye front almost 
reaches the foot line of the glass plate. Generally, about 1 hour for a 120V voltage and a 12% 
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separating gel. For a separating gel possessing higher percentage of acrylamide, the time will 
be longer. 
 
3.11 Circular Dichroism 
Far-UV CD measurements were made using a Chiroscan spectropolarimeter equipped with 
temperature controller. Spectra were recorded in 20mM Tris at pH7.0 using 1 mm path length 
fused silica cuvettes. Protein samples used for CD were at a concentration of 0.05mg/ml. The 
spectra are presented as differential absorbance after baseline subtraction. 
 
3.12 Dynamic Light Scattering 
Dynamic light scattering was measured using a DynaPro Molecular sizing instrument running 
DYNAMICS V6 software. The quartz cuvettes (45 μl) were washed 5 times each with 1% 
Triton/H2O then with dd H2O and dried with compressed nitrogen gas. The exterior surface 
of cuvette was cleaned by wiping with ethanol and lens tissue. The protein concentration used 
was 4mg/ml (or as stated). Each sample was passed through a 0.2μm filter and a minimum of 
20 measurements were recorded at 25°C. 
 
3.13 Mass Spectrometry 
To prepare samples, formic acid was mixed with the protein sample to a final concentration of 
1% (v/v). The sample was first bound to a C5 reverse-phase HPLC column and then eluted 
with an acetonitrile gradient. The eluted fractions from the HPLC column were assessed by 
electrospray ionisation mass spectroscopy. 
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3.14 NMR Methods 
3.14.1 Sample preparation 
Main-chain amide resonance assignments required the spectra detailed in Table 3.10 to be 
collected 
 
Experiment 
 
 
Purpose of experiment 
1H NMR  
 
Sample evaluation 
1H-15N HSQC  
 
Reference spectrum 
1H-15N HMQC  
 
Titration 
HNCACB 
CBCA(CO)NH  
HNCO 
HNCA 
 
 
Backbone assignment 
CBCAHA 
HACA(CO)N  
HCCH-TOCSY 
 
Side-chain assignment 
 
Table 3.10 NMR Spectra required for backbone assignment 
 
All NMR spectra were acquired at 37 ºC on a Bruker Avance spectrometer operating at 600 
MHz for 1H nuclei using a 5 mm inverse detection triple-resonance z-gradient probe. 
Typically, 1D 1H NMR spectra were obtained with 128 transients, consisting of 64 K 
complex points over a sweep width of 8,389 Hz.  Data was processed using an exponential 
Fourier transform window, with a 2.0 Hz line broadening. Residual water was suppressed 
using either pre-saturation, excitation sculpting with gradients solvent suppression or the 
Watergate method (Liu, M., et al. 1998).   
Phase sensitive 2D 1H-15N HSQC NMR spectra were acquired using echo-antiecho gradient 
selection. The 1H acquisition parameters were 0.122 seconds acquisition time, 1 second fixed 
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delay and 2048 complex (t2) points while 256 complex points were collected for the 15N 
dimension.  Thirty two transients were recorded for each spin lattice relaxation time (t1) 
interval.  The 1H and 15N dimensions possessed spectral widths of 14 ppm and 25 ppm 
respectively.  The 15N dimension was zero filled to 256 data points before squared cosine 
apodisation and Fourier transformation.   
 
3.14.2 Data Processing, spectral analysis and resonance assignment 
Standard triple resonance backbone assignment of protein using HNCACB and CBCACONH 
spectra was used (Figure 3.1). The idea is that the HNCACB spectra correlates each NH 
group with the chemical shift of the current residue’s CA and CB (strongly) and that of 
neighbouring residue’s CA and CBs (weakly). The CBCA(CO)NH spectra only correlates the 
NH group of the current residue to the preceding CA and CB chemical shifts. By comparing 
both these spectra, the current residue and its preceding CA CB resonances can be identified. 
The succeeding amide proton chemical shift was identified using the chemical shifts of the 
preceding CA CB to search for the amide giving same chemical shift within the current 
residue’s CA, CB on HNCACB spectra. 
 
3.14.3 NMR Titration 
NMR titration is achieved by recording a 1H-15N HSQC/ 1H-15N Sofast-HMQC spectra of 
the labeled protein. In serial titrations, cross titrations were performed to eliminate the dilution 
of the labeled protein. In cross titration, two samples were prepared; one sample was labeled 
protein only and the second sample had the same concentration of labeled protein and a high 
equivalent (i.e. 10 equivalents) of unlabeled titration partner. During the titraion the 
concentration of labeled protein did not change, so it was not necessary to correct for dilution. 
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Chapter 4: Crystal Structure of OutB 
Aim:  
OutB is known from in vivo studies to be highly important for the assembly of the type 2 
secretion system in several Gram negative bacteria. The aim of this Chapter is to determine the 
structure of the GspB homologue from Dickeya dadantii, OutB, so that its role in assembly of 
the secretion system can be probed at the molecular level. 
4.1 Introduction 
GspB homologues have been described in at least three genera of bacteria, Klebsiella, 
Aeromonas, and the Erwinia complex (including Dikeya dadantii). However, their requirement 
in the secretion process seems to be different. In Aeromonas and Vibrio species, GspB is 
associated with another auxiliary component GspA. GspA is known to interact with 
peptidoglycan (Sandkvist et al. 2011). As a result of this association of a peptidoglycan binding 
protein and GspB, it has been hypothesized that GspB is involved in assembly of the secretin 
possibly by reorganization of the peptidoglycan network or in combination with the inner 
membrane platform. 
 
Dickeya species lack any detectable GspA homologue, so in these bacteria GspB is believed to 
act alone. Previous work published by Shevchik and Condemine 2001, indicated that the GspB 
homologue OutB, from Dickeya dadantti (formerly Erwinia chrysanthemi), is an inner 
membrane protein with a short cytoplasmic tail, transmembrane helix (figure 4.1) and large 
periplasmic domain.  
 
However, fractionation experiments indicate that it could be associated with the outer 
membrane through its C-terminal part. The secretion deficiency of an E. chrysanthemi 
Chapter 4: Structure of OutB 
 
73 
 
outB mutant can be reversed by the addition of an inducer of the kdgR regulon which results 
from the increased expression of the secretin OutD. Also, secretion can be restored in 
an outB negative mutant by introducing the outD gene on a plasmid.  
 
Several experiments suggest an interaction between OutB and OutD. In D. dadantii, the 
presence of OutD stabilizes OutB. OutD expressed in Escherichia coli can be protected from 
proteolytic degradation by the co-expression of OutB. This effect does not require the N-
terminal, transmembrane segment of outB. OutB can be cross-linked with OutD by 
formaldehyde. These results indicate that OutB could act with OutD in the functioning of the 
Out secretion machinery. 
 
4.2 Bioinformatic Analyses 
The major functional domain of OutB is presumed to lie at the C-terminus. This putative 
domain is approximate 170 residues long and resides in the periplasm. Alignment of full length 
GspB protein sequences (figure 4.2) from various species, shows that the transmembrane helix 
(Figure 4.1) and C-terminal domains are the most highly conserved regions across all species. 
Dickeya species appear to have a C-terminal extension of approximately 15 residues which is 
itself highly conserved across members of this genera, but not across GspB homologues. 
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Figure 4.2 Sequence alignment of full length GspB proteins from 8 species with the N-terminal 
transmembrane helix (TMH) highlighted in red. The numbering above is for reference only, and 
does not refer to one particular amino acid sequence. 
Figure 4.1 Hydropathy plot of the OutB sequence of Dickeya dadantii residue number is indicated 
on x-axis and hydropathy score on the y-axis. Note the peak between residues 20-40 indicating the 
transmembrane helix. 
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Given that OutB possess only a short cytoplasmic tail and single transmembrane helix, it is 
safe to assume the major functional domain is the highly conserved C-terminal domain. 
Therefore efforts to solve the structure dealt only with the soluble C-terminal domain rather 
than face the difficulties of dealing with a full length membrane protein, the structure of which 
may reveal few if any insights into the functioning of the protein.  
 
4.3 Expression and Purification of OutB 
DNA encoding the highly conserved region of the periplasmic domain of D. dadantii GspB112-
220, residues 112 to 220, was subcloned into the pGEM-T Easy (Promega) vector, its sequence 
confirmed and then the insert cloned into the pGEX-6P-3 vector encoding a cleavable N-
terminal Glutathione S-transferase (GST) affinity tag.  This construct was transformed in to E. 
coli strain BL21(DE3) for protein expression. 10ml inoculation cultures containing 100µgml-1 
ampicillin were grown at 37°C for 16h typically overnight. These were used to inoculate 1L 
cultures of Lysogeny broth (LB) media. Cells were grown to an OD600 of 0.6 – 0.8 and 
expression induced by addition of 0.2mM isopropyl β-D-1-thiogalactopryanoside (IPTG). 
Induced protein expression was allowed to proceed for 16h at 20°C typically overnight.  
Cells from a 1L culture were harvested by centrifugation at 10,000g for 20min then 
resuspended in 20ml of cell culture of phosphate buffered saline (PBS) containing 0.01M 
phosphate buffer, 0.0027M KCl and 0.137M NaCl, pH 7.4 and lysed on ice by sonication at 
20W with 20 replicates of 10s sonication followed by 20s of cooling. Cell debris was removed 
by centrifugation at 35,000g for 20min and the supernatant was incubated with 2.5ml of 
Glutathione sepharose beads (G.E. Healthcare) for 6h. The glutathione sepharose was then 
collected in a column and washed with 50ml of PBS. 
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On column cleavage of the GST tag required washing Glutathione sepharose with bound GST-
OutB in PreScission  protease (G.E. Healthcare) buffer containing (50mM Tris-HCl, 150 mM 
NaCl, 1 mM EDTA, 1 mM DTT, pH 7.0) and addition of 20µL of PreScission protease to 5ml 
bead volume of glutathione sepharose. Cleavage was at 4°C for 6hr Figure 4.3). Elutate 
containing the tag-less GspB112-220 was then run on a Superdex S200 gel filtration column and 
SDS-PAGE used to assess and confirm purity prior to crystallisation trials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 SDS-PAGE gel showing expression of 
OutB112-220. Lanes from left to right are: 
 
     M   Molecular marker, masses in kDa 
1. Lysed cells 
2. Supernatant 
3. Post digest of GST-Tagged outB with 
PreScission protease 
4. GST column flow through   
5. Post induction with 0.5mM IPTG 
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Figure 4.4 CD Spectra of OutB 112-220 
Circular dichroism spectra of purified OutB (residues 112-220) recorded at 10°C in 
20mM tris pH7.0. The spectrum contains 2 distinct negative peaks at 200nm and 
220nm and a smaller positive peak at 235nm. 
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4.4 Circular dichroism (CD) charecterisation of the periplasmic domain of OutB 
Having confirmed the plasmid construct successfully produced protein and the purification 
protocol allowed for the isolation of uncontaminated protein, it was necessary to characterise 
residues 112-220 of OutB to confirm a folded, stable domain was formed in solution.  
 
The CD spectra of OutB112-220 (Figure 4.4) shows distinct peaks, different to that which 
would be expected from an unstructured polypeptide forming a random coil in solution. This 
indicates that the domain formed by residues 112-220 forms a folded, 3D, tertiary structure in 
solution. The peak present at 232nm may indicate the possibility of extended poly-proline II 
like extended helix. Further analysis was conducted in order to assess the stability of the OutB 
constructed which had been successfully expressed and purified.  
 
Thermal melt CD analysis was conducted, whereby CD spectra are recorded at ever increasing 
temperatures further supports this analysis. The peaks present in the CD spectra at 10°C 
indicated the existence of secondary structure elements; that were lost at temperatures greater 
than 30°C (Figure 4.5). This is a typical stable temperature range for in vitro purified protein. 
Above 30°C, the CD trace was highly characteristic of random coil, unfolded protein. 
 
 
 
 
 
 
 
 
 
Chapter 4: Structure of OutB 
 
79 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 CD Thermal Melt Analysis of OutB 112-220 
Circular dichroism spectra of purified OutB (residues 112-220) recorded at 10°C (red), 
20°C (blue) 30°C (green), 40°C (magenta) and 40°C (black). Spectra are of the same 
sample in 20mM tris pH7.0. Note the disappearance of the negative peaks at 200nm 
and 220nm (and a smaller positive peak at 235nm) as temperature increases. 
 
M
o
la
r 
e
lli
p
ti
c
it
y 
/ 
θ
 
 
Wavelength / nm 
 
Chapter 4: Structure of OutB 
 
80 
 
4.5 Dynamic Light Scattering Measurements 
Dynamic light scattering (DLS) was used to assess the dispersity of particles within purified 
OutB protein and suitability for crystallography studies. DLS analysis showed purified OutB 
112-220 behaved as a 12kDa protein with polydispersity of 13.9% this indicates that OutB 
produced by this method is most likely folded and behaves as a monomer in solution (Figure 
4.6).  
It is generally accepted that proteins with polydispersity of less than 20%, have a very good 
chance of crystallizing. With 13.9% polydispersity, OutB is a good candidate for crystallization 
trials. Crystallization trials of the entire periplasmic domain (residues 112-220) did not yield 
any crystals. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Dynamic light scattering of OutB 112-220 reveals low poly-dispersity, 
compatible with crystallization, but we failed to grow crystals. The hydrodynamic radius is 
consistent with a monomer in solution.  
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4.6 Truncation Mutants 
Crystallisation trials of the full length periplasmic domain (residues 112-220) yielded no 
crystals. It was hypothesised that the C-terminal 15 residues might hamper crystallization, 
perhaps due to flexibility, and were unstructured in solution, and therefore inhibiting crystal 
formation. To overcome this, truncation mutants were generated by mutating glycine residue 
codons 193 and 202 (Figure 4.7) (GGA) to STOP codons (TGA) using Quick Change II 
Mutagenesis.   
Figure 4.7 Sequence alignment of GspB proteins showing the positions where ‘early stop’ 
point mutations were inserted. 
 
An initial crystal hit was obtained using the OutB construct consisting of residues 112 to 202, 
and screened in 96 well plates, in 400nL drops (200nL 1:1 of protein and precipitant). These 
were set up by a Mosquito liquid handling robot and obtained by hanging nanodrop vapour 
diffusion with Molecular Dimensions Structure Screen 1, condition C9 (0.2M MgCl2, 0.1M 
Tris, 30% w/v PEG4000, pH8.5).  
Stop 202 Stop 193 
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Optimisation of this condition was carried out to determine if crystals could be more readily 
obtained in a similar condition. This yielded similar crystals through the pH range 8.0 – 8.5 
and no crystals at PEG4000 concentrations below 20%. It was therefore decided to scale up the 
crystallisation to 1µL drops to aid crystal handling, using the Molecular Dimensions stock 
solution as crystallisation reagent. However, scaling up, to 1-2µL drops in 24 well plates to 
make crystal handling easier proved unsuccessful by vapour diffusion alone. Further crystals 
were however, successfully obtained by whisker streak seeding by using the initial hit as a 
source of seeds.   
 
Figure 4.8 OutB 112-202 Crystals 
Streak seeding resulted in the crystals used for data collection which were grown from 0.2M 
MgCl2, 0.1M Tris, 30% w/v PEG4000 at pH8.5.  The crystals are approximately 0.07 mm in 
length. 
 
 
 
 
4.7 Data collection  
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Selected crystals were removed from the mother liquor and transferred to a solution containing 
mother liquor plus 5% propane-1,2-diol as a cryoprotectant and flash cooled in liquid nitrogen. 
Crystals were transferred and mounted using 0.1mm litholoops. Diffraction data were collected 
at 100K using a Pilatus 300M detector at beam line I04 at Diamond Light Source (DLS), 
Oxfordshire.  Two diffraction images were initially recorded at 0° and 90° to assess the quality 
of the crystal and determine a suitable data collection strategy. 
 
Data were integrated and scaled by XDS through the Xia2 (Winter, 2009) software package 
available through DLS. Several data sets were collected from different crystals (Appendix C) 
and assessed for quality based on statistics such as maximum resolution, I/σ, Rmerge and Rpim. 
All data sets were highly similar, with only small differences in the calculated statistics, as 
provided by XDS. The best data set was chosen for molecular replacement. Statistics given in 
Table 4.1. A total of 1200 images were collected over a rotation range of 120° with a 0.1° 
oscillation angle per image. 
 
 
 
 
 
 
 
 
 
Figure 4.9 Diffraction image 
obtained from an OutB crystal 
A sample diffraction image 
obtained from an OutB crystal 
showing clearly defined spots. 
 
 
 
Chapter 4: Structure of OutB 
 
84 
 
Table 4.1 Crystallographic data statistics for OutB crystal used for model building and 
refinement 
Values for the highest resolution shell are given in parentheses.  
4.8 Molecular replacement  
Ab initio modelling of the OutB sequence by the PHYRE2 server (Kelly, 2009) suggested that 
the structure of OutB may be similar to the structure of the homology region (HR) domain of 
GspC. On this basis, and given that structures of GspC-HR domains are available, molecular 
replacement was tested to see if a solution could be achieved.  Trial and error manipulation of 
the enterotoxigenic E. coli GspC-HR structure (PDB code: 3OSS), including truncation and 
modelling the protein as poly-serine, eventually resulted in a PHENIX Phaser (McCoy, 2007) 
TFZ score of 7.9, approaching the value of 8.0 or greater expected for a genuine solution. 
 
Data collection 
Space group P 43 21 2 
Cell parameters  
a, b, c (Å) 
α, β, γ (°) 
a = b = 36.3, c = 133.2 
 
α = β = γ = 90 
Molecules per asymmetric unit 1 
Wavelength (Å) 1.07 
Resolution (Å) 2.02-36.30 (2.02-2.08) 
Total number of observations 56965 (2403) 
Number of unique reflections 6380 (435) 
Multiplicity 8.9 (5.5) 
Completeness (%) 99.2 (93.6) 
Rmerge (%) 3.6 (57.4) 
Mean <I/σ(I)> 30.6 (3.7) 
Wilson B-factor (Å2) 44.4  
Rpim(I) 0.014 (0.28) 
Rmeas 0.041 (0.69) 
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4.9 Model building and refinement  
PHENIX Autobuild (Terwilliger, 2007) built 7 chains comprising a total of 59 residues of the 
sequence of GspB112-202 into the electron density map giving R-factor and R-free values of 
0.42/0.50, respectively.  Twenty cycles of manual rebuilding and refinement of the structure of 
D. dadantii GspB112-202 yielded a model with reasonable stereochemistry, given the high 
proportion of irregular structure.  Of the 90 residues of OutB112-202 crystalised, residues 115-
198 could be built into the electron density (Figure 3.9); the first three and the last four residues 
are probably disordered or have multiple conformations in the crystal and are not seen. 
 
Initial assessment of the data by XDS suggested space group P41212, however, reprocessing of 
the data in space group P43212 resulted in lower R-factors and is therefore the more likely space 
group.  
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Figure 4.10 
(a) σA-weighted 2Fobs-Fcalc Fourier synthesis, contoured at 1.2σ around β-strands 1 and 2.  The lower 
strand is β1 running right to left (residues: A134, H135, V136, Y137) and the upper one is β2 running 
left to right (residues: S145, V146, T147). 
(b) Same Fourier synthesis map and residues, showing H135 at the centre V136 lower right and the 
electron density around the indole ring and alkyl side chain of the respective residues 
 
(a) 
(b) 
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4.10 Structure Validation  
The stereochemistry of the structure was checked by MolProbity and PROCHECK (Laskowski 
et al. 1993) by plotting the Ramachandran plot. Bond lengths and bond angles of main chain 
and side chains, planarity, chirality, solvent content and torsion angles of main chain (phi and 
psi) were monitored by this program. Any distorted geometry was corrected manually using 
COOT. 
 
The root-mean square deviations (rmsd) from ideal values of bond lengths and bond angles are 
0.013Å and 1.68° respectively with all residues having acceptable phi, psi values (Table 1). 
The final refinement of the structure yielded R-factor/R-free of 0.209 and 0.254 respectively 
at 2.05 Å resolution (Table 4.2).  
 
Table 4.2 Refinement statistics for OutB 
 
 
 
 
Refinement 
Resolution limits (Å) 2.05-34.91 
R-factor (%) 20.85 
R-freeb (%) 25.42 
RMSD bonds (Å) 0.015 
RMSD angle (°) 1.81 
Average B-factor (Å2) 33.38 
Number of protein atoms  666 
Number of solvent atoms  15 
Ramachandran plot statistics 
Residues in most favoured regions 
(%) 
100 
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4.11 Description of the architecture and comparison with GspC-HR and PilP domains  
The polypeptide chain of the periplasmic domain of GspB forms two three-stranded antiparallel 
β-sheets; the β-strands sequentially form the up-down-up β-sheets, so the first sheet comprises 
strands 1, 2 and 3 and the second 4, 5 and 6 (Fig. 3.10).  The two sheets are at approximately 
70° to each other so the structure forms a small barrel with a hydrophobic core.  There are three 
residues in 310-helix conformation in the loop between β1 and β2.   
 
Perhaps the most striking feature of the structure is the quantity of irregular polypeptide, 
between the short β-strands, especially but not limited to the β3/ β4 loop, and at the amino- and 
carboxy-ends of the small β-barrel (Figure 4.11).  DSSP (Kabasch 1983) reveals 58% of the 
residues do not fall into a recognized secondary structure category while 38% of residues form 
β-sheet and 4% form 310-helix. The sequential β-strands are: β1 Ser133-Val136, β2 Ser145-
Leu148, β3 Glu151-Tyr153, β4 Leu163-Gln167, β5 Met172-Ser176 and β6 Glu180 –Leu184. 
Pro141 to Lys143 form the 310-helix.  The 310-helix in the loop between β1 and β2 contains 
a highly conserved Lysine 143 and Arginine 144 which forms a salt bridge to Glu155, also 
highly conserved.  Lysine 143 does not form any contacts within the molecule and therefore is 
likely to have a functional role. 
 
A search for structural homologs using the DALI webserver (Krissinel, 2004) returned: the 
enterotoxigenic E. coli GspC-HR domain used as the molecular replacement search model 
(PDB code:3OSS, Z-score 7.8, rmsd 1.7Å for 60 equivalent CA atoms, sequence identity 17%); 
Pseudomonas aeruginosa PilP from the type 4 pilus system (PDB code:2Y4Y, Z-score 5.6, 
rmsd 2.8Å for 60 equivalent CA atoms, sequence identity 12%); and Dickeya dadantii OutC-
HR (PDB code :2LNV, Z-score 3.5, rmsd 2.8Å for 58 equivalent CA atoms, sequence identity 
10%) as related structures (Figure 3.11).   
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Figure 4.11 Cartoon structure of OutB 
Top: A cartoon of the final OutB structure shown in ribbon form with the β-strands labelled. 
Bottom: A sequence alignment of various GspB proteins, with the position of the β-strands 
present in the model annotated below the sequence as arrows.  
β1 β2 β3 β4 
β5 β6 
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It is interesting that D. dadantii GspB is more similar to enterotoxigenic E. coli GspC-HR in 
structure than to D. dadantii GspC-HR, suggesting that D. dadantii GspB and E. coli GspC-
HR may be closest in function. 
 
The results show that the structure of GspB and E. coli GspC-HR are closely similar supporting 
the view that the role of D. dadantii GspC-HR in assembling the secretion system has been 
assumed in part or whole by GspB, possibly allowing D. dadantii GspC-HR to become more 
specialised in substrate selection. 
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PilP 
P. aeruginosa 
(2Y4Y) 
GspC - HR 
E. coli 
(3OSS) 
T2SS 
GspC - HR 
D. dadantii 
(2LNV) 
T4SS 
Figure 4.12 Structural homologues of D. dadantii OutB.  (a) E. coli GspC-HR (PDB 
code: 3OSS) (b) D. dadantii OutC-HR (PDB code: 2LNV) and (c) P. aeruginosa PilP 
(PDB code: 2Y4Y). The cartoons are coloured from N-terminal end (blue) to the C-
terminal end (red) of the polypeptide chain and the proteins shown in a similar 
orientation to OutB in Figure 4.11 (i.e. with the surface formed by β strands 1-3 at the 
front) 
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4.12 Role of GspB – Structure Function Analysis 
Enterotoxigenic E. coli GspC-HR has a strong interaction with the N0 domain of the secretin, 
GspD (Korotkov, 2011) in comparison to that observed with the corresponding proteins in D. 
dadantii (Gu et al., 2012a).  It is possible that the role of assembling the functional type II 
secretion system fulfilled by GspC-HR in the enterotoxigenic E. coli has been partially taken 
by GspB in D. dadantii freeing up D. dadantii GspC-HR for a greater involvement in other 
functions, such as determining the specificity of substrates secreted by the system.   
 
Calculating the electrostatic surface potentials of OutB reveals a central band of positive 
potential with negative bands either side (Fig. 4.13a). Its structural homologues, D. dadantii 
and E. coli GspC-HR domains, have a neutral central band with negative potential either side 
and are quite similar to one another (Fig. 4.13b, c), while the periplasmic domain of P. 
aeruginosa PilP is more similar to GspB in terms of electrostatic potential, having a 
pronounced central band of positive potential (Fig. 4.13d).  The striking similarity of PilP to 
GspB both structurally and electrostatically suggests PilP they have similar functions in the 
type II secretion and type IV pili systems respectively. 
 
Analysis of the crystallographic symmetry reveals no clues as to the in vivo organisation of 
OutB. The protein is stable as a monomer in vitro as shown by the nature of the crystal and 
through size exclusion measurements (Appendix D). This is unusual for such a protein which 
forms part of a complex, multiprotein system in which interactions are numerous.  
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(a) (b) 
(c) (d) 
Figure 4.13 The electrostatic potential, calculated using macroscopic dielectric constants and a finite-
difference solution of the Poisson-Boltzman equation calculated using APBS software (Dolinsky, 
2007). Potentials are mapped to the surfaces of (a) D. dadantii GspB (b) E. coli GspC-HR (PDB code: 
3OSS) (c) D. dadantii GspC-HR (PDB code: 2LNV) and (d) Pseudomonas aeruginosa PilP (PDB 
code: 2Y4Y). The potential surface is contoured at +1kT/e (blue) and -1kT/e (red). 
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Chapter 5: Interaction studies of OutB  
 
5. 1 Aim 
Pull down assays show a reasonably strong interaction between OutB and the N0 domain of 
OutD (Shevchik et al. unpublished – Figures 5.1 & 5.2). Experimental studies on the GspC 
proteins which are known to interact with this domain of the GspD secretin (OutC-HR with 
OutD-N0 in D. dadantii and GspC-HR and GspD-N0 in enterotoxigenic E. coli) suggest two 
possible modes of interaction: β1-β1 in the crystal structure of Hol et al. 2011 or β1-β3 in the 
NMR experiments of Gu et al. 2012. Here, I introduce cysteine residues on the β 1 strand of 
N0 and β 1 and β 3 strand of OutB in an attempt to trap the complex formed by OutB and 
OutD-N0 and reveal the mode of interaction in vitro. 
5. 2 Background to OutB / OutD interaction 
Work by Shevchik in 2001, indicated that OutB is associated with the outer membrane through 
its C-terminal portion. This suggested an interaction with a protein of the outer membrane, as 
the OutB protein is integral to the inner membrane. Unpublished pull-down assays by Shevchik 
et al (Figure 5.2) confirmed the domains responsible for this interaction (Figures 5.1 & 5.2). 
The C-terminal domain of OutB (residues 112-220) co-purifies with the N-terminal domain N0 
(residues 28-112). Given the structural similarity of OutB to the HR domain of GspC (Chapter 
4) which also interact with the same domain of their respective GspD secretins, it was 
hypothesized that OutB may interact with OutD-N0 domain in a similar way. However, this is 
complicated by the fact that 2 different interactions between GspC-HR and GspD-N0 domains 
have been observed.  
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Figure 5.1 Schematic diagrams of OutB (A), OutC (B) and OutD (C) and their truncated 
derivatives used in the pull down assays. 
 
 
 
 
 
 
 
 
Figure 5.2 Mapping the interaction regions between OutB and OutD. 
Upper panel, whole-cell extracts of E. coli BL21 (DE3) co-expressing GST-OutB112-220 or 
GST-OutC derivatives (upper protein bands, corresponding names are indicated on top) with 
OutD derivatives (corresponding protein bands are indicated with an arrow). 
 
Lower panels, the extracts from the upper panels were used in pull-down assays on Glutathione 
Sepharose. Bound proteins were eluted with sample buffer, separated by SDS-PAGE and 
stained with Coomassie. GST-OutB112-220 or GST-OutC derivatives are indicated by 
asterisks, OutD derivatives, by arrows. 
GST-OutC128-272 and GST-OutC161-272 were used as a positive and a negative controls for 
OutD binding, respectively. Note that OutD28-116 and OutD28-285 but not OutD116-285 
were bound to GST-OutB112-220. 
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5. 3  Models of the OutB / N0 interaction based on GspC-HR / GspD-N0 
 
5.3.1 β1 – β1 Hol et al. 2011  
Hol et al. 2011 have published the HR domain of GspC co-crystalised with the GspD-N0 
domain from Escherichia coli (PDB: 3OSS). In this interaction (Fig. 5.3), the interface between 
GspC-HR and GspD-N0 buries 1280 Å2 of accessible surface area with a calculated ΔG of 
interaction of −5.4 kcal×mol−1 as assessed by the PISA server (Krissinel and Henrick, 2007).  
 
The overall shape of the interface is relatively flat with a small concave area on the GspD 
surface. A total of 18 residues from GspC-HR and 19 residues from GspD-N0 engage in a 
combination of hydrophobic interactions and hydrogen bonds. The first three β strands of 
GspC-HR and the first β strand plus the subsequent α helix (α1) of GspDN0 are the major 
contributors to the interface. The majority of the hydrogen bonds are formed by an antiparallel 
arrangement of strand β1 of GspC-HR and strand β1 of GspDN0 (Table 4.1). This β-strand 
augmentation is frequently observed in protein–protein interfaces (Remaut and Waksman, 
2006).  The residues involved in forming β-strand interactions are listed in Table 4.2.1. 
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GspD-N0 OutD-N0 equivalent  GspC-HR OutB equivalent 
T  6 
A  7 
N  8 
F  9 
K 10 
F 3 
S 4 
A 5 
S 6  
 
F134 
A 133 
I 132 
G 131 
R 130 
H 135 
V 136 
Y 137 
T 138 
 
Table 5.1 Residues involved in the interaction published by Hol et al. 2011 and the equivalent 
residues that would be involved if the interaction between OutD and OutB was identical.  
 
 
 
 
Figure 5.3 A cartoon representation of GspC-HR and GspD-N0 from enterotoxigenic 
E. coli as observed in the crystal structure of Hol et al. 2011 (PDB: 3OSS) Note the 
antiparallel arrangement of the best strands β1 from each protein at the interaction 
interface.  
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5.3.2 β1 – β3 Gu et al. 2012 
An alternative mode of interaction of the GspC-HR and GspD-N0 domains in presented by Gu 
et al. 2012a (Fig. 5.4). In their experiments the homologous proteins from the D. dadantii Out 
system were used (OutC-HR and OutD-N0). The model was proposed on the basis of NMR 
chemical shift mapping. In the experiments, one protein was isotopically labelled, the other 
NMR silent. The chemical shifts observed when unlabeled HR domain was added were mapped 
to the surface of the N0 domain and vice versa to determine the 2 surfaces involved in the 
interaction.  
 
The chemical shifts observed reveal that residues on strands β1, β2, and β3 of the HR domain 
are involved in the interaction and residues on β1 of N0 are most affected (Table 4.2). Residues 
on β1 and α2 of the N0 domain were the most affected, but the shifts were relatively small. 
Small shifts were seen for residues: Thr63, Ile64, Ser65, Phe79, Ser83, and Val84. 
 
The model brings β1 of HR and β3 of N0 together such that they could form a continuous anti-
parallel β-sheet across both domains HR and N0. It is important to note that this is only a model 
of the interaction and the position and conformation of interfacial residues has not been defined 
experimentally. Met101 appears to be an important hydrophobic residue at the interface with 
the more remote Asp141 also showing large chemical shifts. The interaction between the D. 
dadantii HR and N0 domains is weak, but it does persist in the presence of 150 mM sodium 
chloride. 
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OutD-N0 OutC-HR OutB equivalent 
Thr 63 
Ile 64 
Ser 65 
Phe 79 
Ser 83 
Thr 98     - β1 
Gly 99     - β1 
Val 100   - β1 
Met 101  - β1 
Ala 102   - β1 
 
A 134 
H 135 
V 136 
Y 137 
T 138 
Table 5.2 Residues involved in the interaction published by Gu et al. 2012a and the equivalent 
residues that would be involved if the interaction between OutD and OutB was identical.  
 
 
 
 
Figure 5.4 A cartoon representation of GspCOutC-HR and GspDOutD-N0 from D. dadantii as 
proposed on the basis of the NMR experiments of Gu et al. 2012a (GspCOutC-HR structure 
PDB: 2LNV / GspDOutD-N0 homology model from Modeller v9.1) Note the antiparallel 
arrangement of the best strands β1 from each protein at the interaction interface.  
 
N.B. In several members of the HR domain family of structures, there is a fourth β-strand in 
the second β-sheet, hence the numbering scheme misses β4. This strand is more dynamic in 
solution than the other six β-strands, which are present in all of the NMR ensemble 
structures 
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5.4 Generation of cysteine mutants of OutB and N0 
The structure of GspB as determined in Chapter 4, was superimposed over the GspC-HR 
domain in both of the previous structures, and the equivalent residues from β1most likely to be 
involved in an interaction were determined to be valine 136, tyrosine 137 and threonine 138. 
In the construct encoding only the periplasmic domain of GspB, residues 112-220, these were 
V25, Y26 and T27 respectively.  
Using the same process, the corresponding residues of OutD on either β1 (serine 4, alanine 5 
and serine 6) and β3 (threonine 63, isoleucine 64 and serine 65) were selected and made using 
Strategene Lightnigh Quick Change II method (Chapter 3). 
 
 
5.5 Disulphide cross-linking studies with addition of crosslinking reagents 
Homobifunctional, maleimide compounds (Figure 5.5) can be used as crosslinkers for 
conjugation between sulfhydryl groups (-SH) which are present in the R-groups of cysteine 
Figure 5.5 Maleimides 
Top: Bismaleimidoethane (BMOE) is capable of crosslinking sulphydryl groups 8Å apart. 
Bottom: Bismaleimidobutane (BMB) can span 10.9Å 
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residues. Such bismaleimide crosslinkers are commonly used to explore and characterize 
protein structure (i.e., oligomerization) or protein interactions.  
Because BMOE and BMB have the same reactivity but differ in length, the relative success of 
these three reagents in forming crosslinks between sites in a protein oligomer or interaction can 
assist in determining intra- and intermolecular distances. 
 
Reaction of a sulfhydryl to the maleimide group results in formation of a stable thioether 
linkage (Figure 5.5), which cannot be cleaved by reducing agents or physiological buffer 
conditions. Reaction of maleimides is very specific to sulfhydryls at pH 6.5 - 7.5. Although 
maleimides will react to primary amines at pH > 8, the rate is 1000 times slower than the 
reaction to sulfhydryls at pH 7. Unlike iodoacetamides, maleimides do not react with tyrosines, 
histidines or methionines, so it is possible to ensure crosslinking only occurs between surface 
exposed cysteine residues.  
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5.6 Results 
5.6.1 OutD-N0 homodimers – A useful positive control 
Each of the mutants detailed in Table 5.3 below were purified separately to individually 
optimize expression of each mutant and to confirm the solubility of the purified protein. 
Subsequently, controls were run of the cysteine mutant proteins under both reducing and 
oxidizing conditions.  
OutD-N0 Mutants OutB Mutants 
S4 
A5 
S6 
 
β1 
V136C 
Y137 
T138 
 
 
β1 
T63 
I64 
S65 
 
β3 
Table 5.3 A list of the mutants generated A list of the mutants generated to test interactions 
between β1 of OutB and both β1 and β3 of OutD-N0 
 
Initially cysteine mutant proteins were purified in the same buffer as the non-mutant form. 
However, it was discovered that mutations S4C, A5C and S6C of OutD-N0 formed 
homodimers during the purification process, so it was necessary to add DTT to the lysis and 
size exclusion buffers. 
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5.6.2 Difficulty in distinguishing OutB/OutD heterodimer from OutD homodimers 
Due to the similarity in size between the 2 domains (OutD-N0: / OutB112-202: ) it was difficult 
to determine by SDS-PAGE analysis alone, if the higher molecular weight species present upon 
addition of glutathione (used as an oxidizing agent) was due to the formation of homo- or 
heterodimers. Therefore, mutant OutB proteins were purified leaving the GST tag intact, 
thereby increasing the mass of the respective OutB domain to 47kDa (36kDa glutathione s-
transferase tag + 11kDa for the functional domain).  
 
 
 
 
 
 
Figure 5.6 20% SDS-PAGE gel showing the addition of DTT prevents the formation 
of OutD-N0 mutant S4C from forming homodimers. Marker ladder was loaded into 
lanes 1 and 8. 2. non-mutant OutD-N0, 3. OutD-N0 S4C 4. 3 + 2mM DTT 5. 3 + 
5mM DTT 6. 3 + 10mM DTT 7. 3 + 20mM DTT 
Dimeric OutD-
N0 (22.6 kDa)  
Monomeric OutD-
N0 (11.3 kDa)  7 
17 
23 
30 
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5.6.3 Addition of crosslinking reagents to aid disulphide formation 
As shown in figures 5.7 and 5.8, no crosslinking was observed – indicated by the absence of 
any proteins with a molecular mass greater than GST-OutB monomer (36,482 Da). In order to 
aid in the formation of covalent bonds between GST-OutB and OutDN0, bismalemide 
crosslinking reagents (BMOE and BMB) were added to attempt to bridge the gap between any 
cysteines which were close in space, but not quite close enough to form disulphides, also failed 
to link the 2 proteins together. However, this also failed to link the two proteins. 
 
In order to test the validity of this experiment, and confirm that the cysteine was available to 
the bismalemide reagent, the mass was determined of protein treated with BMB under, 
oxidising conditions, using liquid chromatography – mass spectrometry (ESI-MS) (Figures 5.9 
and 5.10).   
 
The mass of a single species present in solution was determined to have a molecular weight of 
36,739/36,740. This is very close the expected mass of 36,730 for GST-OutB with a covalently 
attached BMB molecule on the surface (molecular masses of 36482 and 248 respectively). The 
same was done for the cysteine mutants of OutD-N0, however, this was inconclusive in 
confirming addition of the bismalemide crosslinkers under oxidising conditions, possibly due 
to dimer formation (Data in Appendix E). 
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Figure 5.9 Bottom panel: The direct readout from electrospray ionization mass 
spectrometry of GST-OutB mutant Y137C treated with 1,4-bismaleimidobutane 
(BMB). The x-axis is the mass-to-charge- ratio of the ion, and the y-axis is the 
relative intensity of the species. Top panel: The calculated mass of the single 
species, from which the bottom frequency distribution of charged particles arose.  
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Figure 5.10 Bottom panel: The direct readout from electrospray ionization mass 
spectrometry of GST-OutB mutant T138C treated with 1,4-bismaleimidobutane 
(BMB). The x-axis is the mass-to-charge- ratio of the ion, and the y-axis is the 
relative intensity of the species. Top panel: The calculated mass of the single 
species, from which the bottom frequency distribution of charged particles arose.  
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5.7 Conclusions 
Cysteine scanning mutagenesis was used to test if the interaction observed between the N0 
domain of OutD and the inner membrane protein OutB was similar to the other interactions 
observed with the N-terminal domain of the secretin. 
Interactions previously observed by pull down assays were used to model possible residues, 
which if the interactions were similar, could kinetically ‘trap’ the complex by forming an 
artificial disulphide bond. 
Cysteine point mutations were successfully introduced on the 1st beta strand of OutB (residues 
V136, Y137, T138) and the 1st and 3rd beta strands of the N0 domain (S4, A5, S6 and  T63, 
I64, S65 respectively). The introduction of cysteines on the first beta strand of N0, lead to the 
formation of homodimers, as assessed by SDS-PAGE analysis. This provided the added 
complication as N0 homodimers (22 kDA) were similar in size for the anticipated OutB-OutD 
heterodimers (20 kDa). To overcome this problem, OutB was purified with its N-terminal GST-
tag intact, so as to provide a greater difference in mass between N0-N0 dimers and any possible 
OutB+N0 complexes.  
 
Unfortunately, no increases in mass were visible on SDS-PAGE gels upon addition of an 
oxidising agent to induce disulphide formation. The addition of crosslinking reagents of 
different lengths (BMOE: 7Å and BMB:10.9Å) in order to attempt to bridge the gap between 
any cysteines which were close in space, but not quite close enough to form disulphides, also 
failed to link the 2 proteins together.  
 
Addition of the crosslinking reagent to the protein under the experimental conditions was 
checked using GC-MS (gas chromatography, mass spectrometry) in order to check the validity 
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of the experimental method. Given that an interaction was observed using a pull down assay, 
it was decided to investigate the interaction further using more sensitive techniques than 
cysteine scanning mutagenesis.  
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Chapter 6: Solution NMR studies on the structure of 
OutB and its interaction with N0 
 
6.1 Aim  
To complement X-ray studies of the structure of OutB and investigate its interaction with 
OutD-N0.   
6.2 Introduction 
As it did not prove possible to co-purify OutB and OutD-N0, the best available method to 
determine the atomic details of the interaction between these two proteins was solution NMR.  
 
6.3 Assignment of OutB 
A standard triple resonance backbone assignment approach was used to assign the amide 
protons of OutB 112-220 using HNCACB and CBCACONH spectra. The HNCACB spectra 
correlates each NH group with the chemical shift of the current residue’s CA and CB(strongly) 
and that of neighboring residue’s CA and CBs (weakly). The CBCA(CO)NH spectra only 
correlates the NH group of the current residue to the preceding CA and CB chemical shifts. By 
comparing both these spectra, the current residue and its preceding CA / CB resonances can be 
identified. The succeeding amide proton chemical shift was identified using the chemical shifts 
of the preceding CA CB to search for the amide giving same chemical shift within the current 
residue’s CA, CB on HNCACB spectra. Proline residues, where amide proton is absent, were 
not assigned. Assignment of side-chain resonances was also not performed.  
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Figure 6.1 15N HSQC of OutB  
The HSQC of OutB was measured and a partial assignment of the N-H amide resonances 
was achieved using the HNCACB and CBCACONH spectra.  
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6.4 Interaction of OutB and N0 
The interaction initially revealed through pull down assays (Chapter 4) was probed via NMR 
methods. By labelling each protein in turn and adding unlabeled partner protein, changes in the 
amide chemical shifts were observed in both experiments (Recording 1H-15N HSQC spectra of 
an isotopically labeled OutB protein and titrating unlabeled [14N abundant] OutD-N0 and the 
reverse labelling scheme). In titrations, cross titrations were performed to eliminate the dilution 
of the labeled protein. In cross titration, two samples were prepared; one sample was labeled 
protein only and the second sample had the same concentration of labeled protein and a 5 
equivalents of unlabeled titration partner. During the titration the concentration of labeled 
protein did not change, so it was not necessary to correct signal intensities due to dilution. 
 
The interaction between OutB and OutD-N0 appears to be strong. Upon titration of the 
unlabeled partner protein, a new and well dispersed set of signals were observed in the 
15N-HSQC spectrum of both proteins (Figures 6.2 and 6.3). The peaks corresponding to the 
“free” form became weaker and a new spectrum of peaks corresponding to the “bound” form 
appear and become more intensified. The co-presence of the “free” and “bound” forms show 
that the interaction between OutB and OutD-N0 is in “slow exchange” (on the NMR time scale 
– miliseconds) and thus indicates the tight binding between the two proteins.  
 
Since the titration experiments used 40μΜ of labeled OutB with addition of 1.3 equivalents of 
OutD-N0, all the OutB shifted to the “bound” state, indicating that the stoichiometry of the 
complex would be a 1:1 ratio, with a Kd < 40μΜ. 
 
 
Chapter 6: NMR Studies of OutB / OutD Interaction 
 
114 
 
 
Figure 6.3 15N HSQC of OutD-N0  
The HSQC of OutD-N0 was measured in the absence (green) and presence 
(red) of 5 molar equivalents of unlabeled OutB. 
 
Figure 6.2 15N HSQC of OutB  
The HSQC of OutB was measured in the absence (red) and presence (blue) of  5 
molar equivalents of unlabeled OutD-N0. 
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6.5 Homology modelling of OutD-N0 
Sequence identity between OutD-N0 and GspD-N0 is 52%. This indicates that there is a high 
likelihood of both N0 domains sharing a similar fold. SWISS-MODEL 
(http://swissmodel.expasy.org/) and MODELLER (https://salilab.org/modeller/) were used to 
generate homology models of OutD-N0 according to sequence alignment and homology with 
the GspD-N0 structure (PDB:3EZJ). The structures of OutD-N0 generated by the two different 
servers are based on the same known structure. The resultant models are therefore very similar 
with a backbone RMSD of 0.25Å (Figure 6.4). The generated models give some idea of the 
molecule backbone orientation.  
 
 
 
 
 
Figure 6.4 Homology based OutD-N0 structure prediction. SWISS-MODEL 
generated structure in green. MODELLER generated structure is cyan. (Adapted 
from Gu et al., 2011) 
Chapter 6: NMR Studies of OutB / OutD Interaction 
 
116 
 
6.6 Attempts at modelling the complex based on chemical shift analysis 
Both OutB and OutD-N0 showed some peak shifting in their respective HSQC spectra when 
titrating with the other (Figures 6.2 and 6.3 respectively). This indicates that there are some 
local structural changes as a result of the two proteins interacting. Some detected peak shifts 
were greater than others such that the peaks originating from the bound or unbound forms did 
not overlap. 
This indicates a larger degree of local structure perturbation as a result of binding, and it is 
therefore possible to surmise that these areas are closer to the binding interface, than those 
residues showing only a small degree of change in their chemical shift values.  
As a result, peaks that showed a large degree of chemical shift perturbation, and no longer 
overlapped once saturated with binding partner, were selected and mapped to the surfaces of 
their corresponding proteins (Figures 6.5 and 6.6). 
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Figure 6.5 Top: 15N-HSQC of OutB in the absence (red) and presence (blue) of 
unlabelled OutD-N0. Bottom: 15N-HSQC of OutD-N0 in the absence (green) and 
presence (red) of unlabelled OutD-N0 
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Figure 6.6 Mapping the largest chemical shifts to protein surfaces 
Mapping the largest chemical shifts to the surfaces of OutB (top) and OutD-N0 (bottom). 
The residues circled in Figure 5.5 are shown in blue, with the rest of the protein surface 
show in either green (OutB) or red (OutD-N0) 
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Mapping the largest chemical shifts to the surfaces of OutB and OutD-N0 resulted in each case, 
to a reasonably well defined, discrete area on the surface of each protein: a surface formed by 
beta-strands 1 through 3 of OutB and a surface proximal to beta-1 of OutD-N0 (Figure 6.6). 
As a result, it was possible to specify these surfaces to the high ambiguity drive protein-protein 
docking (HADDOCK) server, in order to model the lowest energy configuration in which the 
2 proteins may interact. The resultant model is shown in Figure 6.7 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90° 
Figure 6.7 Model of the interaction between OutB and OutD-N0 based on the 
chemical shift analysis outlined above, with OutB in green and OutD-N0 in blue. 
The residues which showed large chemical shifts and we used as docking parameters 
are shown in red. 
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6.7 Filtered NOE Experiments 
 
The Nuclear Overhauser Effect (NOE) can be used to establish if a protein-protein interaction 
is a specific or non-specific interaction. If 2 atoms, 1 from each partner protein, are continually 
close together, for a long enough period of time for magnetisation to be transferred between 
them, this would indicate they are involved in, or near to, a defined binding site. If no such 
interactions are observed, it is assumed that the changes seen in the HSQC measurements are 
due to a non-specific or generalised interaction between the two proteins. 
 
To identify only intermolecular NOEs between 2 proteins, and avoid also measuring 
intramolecular NOEs within the same protein, it is necessary to isotopically label one and not 
the other. It is then possible for a pulse sequence to omit intramolecular NOEs from within 
both labeled and unlabeled constituents. The filtered experiments run are designed to detect 
inter-molecular contacts, using the fact that one component of the complex is labelled and one 
not.  
 
The pulse sequence starts by eliminating the 1H{15N/13C} magnetisation, while retaining that 
originating from the unlabeled component. Then 1H chemical shift of this 1H{14N/12C} 
magnetisation is recorded, and gives one of the indirect dimensions. Then an NOE mixing 
period allows this magnetisation to transfer over to the labelled component, if the hydrogen in 
question is close, (<6 angstroms) to the interface. The "acceptor" hydrogen is then measured, 
along with its attached heteronucleus.  
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Using 13C / 15N doubly labelled protein-protein, NOEs can be selective observed be so called 
isotope filtered and edited experiments. In this experiment, OutB was labelled uniformly with 
15N and 13C while OutD-N0 is at the natural isotopic abundance. 
 
 
 
 
 
Figure 6.8 Projection of the isotope filtered experiment  
 
OutB was isotopically labelled (15N / 13C) and OutD-N0 was not. The chemical shift of 
the OutB ‘donor’ protons is shown along the x-axis and the chemical shift of the receiver 
protons on OutD-N0 on the y-axis. Note numerous receiver peaks at 4.7ppm (red line). 
These are solvent exchange hydrogens where the receiving proton of the observed NOE is 
water.  
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The presence of observable NOEs (Figure 6.8) between the 2 proteins in the complex indicates 
that 2 atoms, 1 from each partner protein, are continually close together, for a long enough 
period of time for magnetisation to be transferred between them, indicating they are involved 
in, or near to, a defined binding site. 
 
6.8 Discussion 
In this chapter it has been demonstrated that the inner membrane protein OutB of the type 2 
secretion system in Dickeya dadantii forms a strong interaction with the N-terminal domain 
(N0) of the outer membrane secretin OutD. This is similar to the GspC proteins in other species. 
 
Enterotoxigenic E. coli GspC-HR has a strong interaction with the N0 domain of the secretin, 
GspD (Korotkov, 2011) in comparison to that observed with the corresponding proteins in D. 
dadantii (Gu et al., 2012a).  It is possible that the role of assembling the functional type II 
secretion system fulfilled by GspC-HR in enterotoxigenic E. coli has been partially taken-up 
by OutB in D. dadantii freeing up D. dadantii OutC-HR for a greater involvement in other 
functions, such as determining the specificity of substrates secreted by the system.   
 
Based on the similarity of OutB with various GspC structures, a model was presented on how 
OutB and OutD may interact. This model was generated by mapping the largest chemical shifts 
that occur in the HSQC of each respective protein as a result of binding the other, to their 
respective surfaces and using these residues, which experience the largest chemical shifts, as 
docking parameters for the modelling programme HADDOCK.  
 
It is entirely plausible, though not demonstrated by experimental means, that the first β-strand 
of GspB could interact with the first β-strand of GspD-N0; this brings two small hydrophobic 
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patches together involving the conserved Ala and Val on the surface of β1 of GspB and 
conserved Phe of GspD-N0.  
 
Calculating the electrostatic surface of the region of GspB that may interact with N0 reveals a 
central band of positive potential with negative bands either side (Chapter 3, Fig. 3.13, other 
data not shown).  D. dadantii and E. coli GspC-HR domains have a neutral central band with 
negative potential either side and are quite similar to one another (Chapter 3, Figure 3.13b, c), 
while the periplasmic domain of P. aeruginosa PilP is more similar to GspB in terms of 
electrostatic potential, having a pronounced central band of positive potential.  The striking 
similarity of PilP to GspB both structurally and electrostatically suggests they have similar 
functions in the type II secretion and type IV pili systems respectively. 
 
The results show that OutB and OutD interact. Given that the structures of GspB and E. coli 
GspC-HR are closely similar supports the view that the role of D. dadantii GspC-HR in 
assembling the secretion system has been assumed in part or completely by GspB. This may 
possibly allow D. dadantii GspC-HR to become more specialised in substrate selection. A role 
which is supported by various studies (Gu et al 2012a, Pineau et al. 2014). 
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Chapter 7: Conclusion and future directions 
 
7.1 Work completed 
Here, I have made truncations of OutB and successfully shown that its architecture is similar 
to that of the HR domain of OutC. The truncation OutB 112-202 gave crystals that diffracted 
well. The structure comprises two three-stranded antiparallel β-sheets; the β-strands 
sequentially form the up-down-up β-sheets, so the first sheet comprises strands 1, 2 and 3 and 
the second 4, 5 and 6.  The two sheets are at approximately 70° to each other so the structure 
forms a small barrel with a hydrophobic core.  There are three residues in 310-helix 
conformation in the loop between β1 and β2.  Perhaps the most striking feature of the structure 
is the quantity of irregular polypeptide, between the short β-strands, especially but not limited 
to the β3/ β4 loop, and at the amino- and carboxy-ends of the small β-barrel. This is a new 
structure, refined coordinates and observed structure factors are deposited in the PDB with 
accession code 4WFW. 
Pull-down assays had shown that OutB binds to the N-terminal domain (N0) of OutD. Attempts 
to cross-link OutB and N0 were surprisingly unsuccessful, possibly hampered by the proclivity 
of N0 to form cross-linked homodimers. Self-association of N0 had not been seen before and 
the evidence suggests it involves β1- β1 interactions.  
NMR analyses suggest that OutD-N0 has a reasonable affinity for OutB (< 40µM) and that the 
interaction involves association of residues on the first beta-strand of each protein.  
Although there are only weakly similar sequence homologs to OutB, analysis of the structure 
showed that structural homologs of OutB are present in the T2 and T4P secretion systems. 
Analysis of the surface potentials of these structures using a finite-difference solution of the 
Poisson-Boltzman equation calculated using APBS software, indicated that although the GspC 
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proteins are structurally similar to OutB, these 2 proteins although similar to one another, have 
very different surface charge potentials - unsurprising given the lack of sequence similarity to 
OutB. 
What is surprising however, is that OutB bare remarkable similarity to the inner membrane 
protein of the Pseudomonas aeruginosa T4P system, PilP. PilP is known to interact with the 
cognate secretin of the T4P system, a similar function to that of OutB. This suggests that the 
largely similar charge distribution on these two proteins may play a similar role, either in 
interactions with secretins, or in an unknown role they play. 
 
7.2 Future work directly related to this Thesis 
Since its discovery nearly 25 years ago, much work has been performed to try and understand 
the T2SS. In the past decade, there have been great advances in understanding the molecular 
structure of individual components of the T2SS. These structures have been solved principally 
by X-ray crystallography as well as a few domains of component proteins by solution NMR. 
 
In this Thesis I have focussed on elucidating the molecular details of the interaction of the 
T2SS outer membrane secretin, OutD, with the inner-membrane protein OutB in the bacterium 
Dickeya dadantii. The discovery of the interaction between OutB and OutD, presented in this 
thesis, has raised numerous questions in terms of the temporal arrangement and order in which 
these interactions occur. Given that the secretin in D. dadantii is now known to interact with 
no fewer than 3 proteins (Gu et al. 2012b, Korotkov et al. 2011, this work); the inner membrane 
platform component OutC, its cognate pilotin OutS and now OutB. Both the latter two of these 
proteins (OutS and OutB) are implicated in assembly of the T2SS system as a whole.  
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Given these numerous interactions the next, and technically more challenging task, is to 
investigate the dynamic interplay between all these interactions. Are there multiple interactions 
present to allow redundancy in assembling the T2SS, given its importance in virulence and 
survival of bacteria, or is the function of these multiple components within the T2SS gene 
cluster more subtle than purely ‘assembly’. The biological significance of this interaction in 
Dickeya dadantii has also been discussed. 
It is possible that OutB and OutC bind to the secretin at different sites. In order to answer this, 
it is necessary to interpret the NOE data and determine the residues which are close in space as 
a result of binding. A full assignment of OutB and OutD-N0 in complex is required. However, 
it may be quicker to determine the exact nature of the complex if OutB and OutD-N0 domains 
can be co-crystalised and an X-ray structure determined.  
Solving the phase problem of such a structure by molecular replacement should be 
comparatively straightforward given that structures are known for each of the components; 
thereby avoiding one of the major bottle necks of X-ray crystallography.  
However, there is still limited knowledge of how the components interact and assemble to form 
a functional system, and even whether the system exists fully assembled, waiting for substrates 
to secrete, or assembles only when required. However, establishing this interaction still leaves 
many questions about the functionality of the T2SS unanswered.  
 
The exact role of the GspA / B complex observed in some species and the absence of GspB in 
other systems still remains an unanswered question. I hypothesis this is possibly due to the 
diverse thickness of peptidoglycan in different bacterial species, which may necessitate or 
negate the requirement of GspA to provide energy to the process performed by GspB.The 
absence of GspB homologues I hypothesis is to do with the propensity of the secretin to self 
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multimerize, so that in those species where the cognate secretin has a high self-affinity, a GspB 
homologue is not required to organise the secretin correctly.  
 
7.3 Other unanswered questions related to the T2SS  
 
7.3.1 Cryogenic Electron Microscopy & single particle and tomography work could be 
used to assess the way the T2SS nanomachine is organized in detail 
 
A major advantage of cryoelectron microscopy is that specimens can be observed in a more 
native, physiological condition - without having to be stained or fixed in any way. This is in 
stark contrast to X-ray crystallography, which requires crystallisation of the protein(s) under 
highly artificial conditions, which can lead to functionally irrelevant conformational changes. 
Transmission electron microscopy has been successfully used to image entire, isolated T3SS 
needle complexes from S. typhimurium (Schraidt et al. 2010).  
Cryoelectron microscopy, could if applied successfully to the T2SS, yield important results 
elucidating the exact arrangement of the inner membrane platform, its stoichiometric 
arrangement and the exact nature of the associated between the ATPase, IM platform and 
pseudopilins. This would be essential knowledge, in order to shed light on how energy transfer 
occurs throughout the system. 
 
7.3.2 The Export Mechanism and energy transduction is poorly understood 
At the moment the only known ATPase, associated with the T2SS, are GspE homologs. These 
proteins are associated with the cytoplasmic side of the inner membrane and it is unclear how 
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energy derived from ATP hydrolysis on one side of the membrane can be transferred 
(presumably via the inner membrane platform proteins) to drive pseudopilus assembly in the 
periplasmic space, and secretion through the outer membrane secretin pore.   
Although there have been great advances in understanding the molecular structure of individual 
components of the T2SS, most of these new structures have been of soluble domains from 
constituent proteins not the full length proteins. This is understandable given the current 
difficulties in handling and working with membrane proteins. However, given that an intrinsic 
purpose of this system is to span 2 membranes, it will be necessary to establish the structure of 
full length proteins in order to understand how the numerous proteins of the inner membrane 
interact and pack.  
The IMP is much more heterogeneous than both the outer membrane pore (homo-multimeric), 
and pseudopilus, (consisting of major and minor pseudopilins) consisting of at least 5 proteins 
(homologs of GspF, L, M, C and E). I have begun work on cloning and purifying the GspF 
homolog from D. dadantii, OutF (Appendix G). This protein is the only protein of the inner 
membrane platform (IMP) to possess more than 1 transmembrane helix, and is therefore 
presumed to form the ‘core’ or centre of an IMP complex, given its presumably inherent greater 
stability within the membrane. Determining a structure of the integral membrane proteins of 
the IMP will be essential in further understanding the structure and function of the T2SS and 
its role in pathogenesis. 
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7.3.3 Exoprotein Selection  
A fundamental problem related to the T2SS, and many other bacterial secretion systems, is 
how fully folded proteins are distinguished from those that are not secreted. Proteins routed 
through the  T2SS are known to acquire a highly ordered structure in the periplasmic space 
before translocation across the outer membrane and release to the environment (Hirst and 
Holmgren, 1987; Pugsley, 1992; Poquet et al., 1993). Consequently, they are expected to 
contain a targeting motif in their folded structure, as no linear, amino acid signal has been 
detected.  
In several studies, the information needed for active extracellular targeting has been located 
to segments covering 60–80 amino acids of the mature protein (Lu and Lory, 1996; 
Sauvonnet and Pugsley, 1996; Lindeberg et al., 1998, Palomaki et al. 2002). But in no cases 
have the underlying recognition motifs been unveiled. It is hypothesised that the actual 
targeting motifs in even these proteins should require a far smaller number, perhaps <10, 
residues than the 60–80 amino acids present in the primary sequence of the secretion 
promoting segments (Palomaki et al. 2002). 
A study using chimeras made between the PelC protein of E. chrysanthemi and the PelL of E. 
carotovora (Lindeberg et al., 1998), showed a single C-terminal region composed of loops as 
a primary source of species-specific targeting information of PelC. Two helical regions also 
reported to be required for secretion were suggested to be needed for the proper positioning 
of the loop region, but results from this an other studies are still inconclusive as to the 
potential nature of a 3D structural motif that may target proteins for secretion by the T2SS. 
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7.3.4 Concluding Remarks 
As more information is collected, the organization of the T2S and T4P machineries will 
become ever clearer, and it will be possible to understand in detail the precise mechanisms by 
which these two related systems function. TO understand fully the processes through which 
these systems are regulated, the way in which mechanical energy is transduced from 
cytoplasmic ATPase(s) across the inner membrane to assemble components in the periplasm, 
& the selection of exoprotein substrates are all areas in this field of research that require 
further research.  
 
Studies in the T2SS have already started to shed light on exoprotein selection, showing that 
the N-terminal domains (NTD) of the secretin in K. oxytoca could be exchanged with that of 
Erwinia chrysanthemi with no defect in Klebsiella-specific protein secretion (Guilvout et al. 
1999). By contrast, a direct interaction between the secretin with secreted substrates was 
observed in E. chrysanthemi, suggesting that this N-terminal domain plays a role in Erwinia-
specific secretion (Bouley et al. 2001). Answering these questions will help to generate a 
more complete model of how both the T2S andT4P systems function. 
Appendix 
 
131 
 
Appendix 
(A) 1:  pGEX-6P-3 Plasmid 
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(A)  2:   pET-14b Plasmid 
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(B)      Mutant primers 
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(C) X-ray data sets 
Summary data for Project: mx7197v39 Crystal: x2681collectM4S11 
Dataset: SAD  
 Overall InnerShell OuterShell 
Low resolution limit  36.33 36.33 2.21 
High resolution limit  2.15 9.62 2.15 
    
Rmerge (within I+/I-)  0.038 0.023 0.574 
Rmerge (all I+ and I-)  0.040 0.024 0.585 
Rmeas (within I+/I-)  0.043 0.027 0.710 
Rmeas (all I+ & I-)  0.043 0.027 0.660 
Rpim (within I+/I-)  0.020 0.012 0.411 
Rpim (all I+ & I-)  0.016 0.010 0.298 
Rmerge in top intensity bin  0.024 - - 
Total number of observations  37835 453 1555 
Total number unique  5352 83 360 
Mean((I)/sd(I))  25.9 60.3 2.5 
Mn(I) half-set correlation CC(1/2)  0.999 0.999 0.818 
Completeness  99.6 99.3 97.6 
Multiplicity  7.1 5.5 4.3 
    
Anomalous completeness  98.4 100.0 89.8 
Anomalous multiplicity  4.0 4.6 2.2 
DelAnom correlation between half-
sets  
-0.004 -0.039 0.007 
Mid-Slope of Anom Normal 
Probability  
0.936 -  
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Summary data for Project: mx7197v39 Crystal: x2682collectM4S21 
Dataset: SAD  
 Overall InnerShell OuterShell 
Low resolution limit  36.31 36.31 2.15 
High resolution limit  2.10 9.39 2.10 
    
Rmerge (within I+/I-)  0.039 0.029 0.640 
Rmerge (all I+ and I-)  0.042 0.030 0.683 
Rmeas (within I+/I-)  0.046 0.035 0.761 
Rmeas (all I+ & I-)  0.046 0.034 0.747 
Rpim (within I+/I-)  0.025 0.019 0.406 
Rpim (all I+ & I-)  0.019 0.016 0.298 
Rmerge in top intensity bin  0.026 - - 
Total number of observations  32594 327 2494 
Total number unique  5622 92 407 
Mean((I)/sd(I))  19.8 38.6 2.6 
Mn(I) half-set correlation CC(1/2)  1.000 1.000 0.846 
Completeness  99.8 98.8 99.9 
Multiplicity  5.8 3.6 6.1 
    
Anomalous completeness  98.3 100.0 99.1 
Anomalous multiplicity  3.2 3.6 3.2 
DelAnom correlation between half-
sets  
-0.029 -0.254 -0.040 
Mid-Slope of Anom Normal 
Probability  
1.023 - - 
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Summary data for Project: mx7197v39 Crystal: 
x26812collectM4S121 Dataset: SAD  
 Overall InnerShell OuterShell 
Low resolution limit  36.31 36.31 1.99 
High resolution limit  1.94 8.68 1.94 
    
Rmerge (within I+/I-)  0.029 0.027 0.487 
Rmerge (all I+ and I-)  0.030 0.029 0.525 
Rmeas (within I+/I-)  0.032 0.030 0.583 
Rmeas (all I+ & I-)  0.032 0.031 0.584 
Rpim (within I+/I-)  0.012 0.012 0.315 
Rpim (all I+ & I-)  0.010 0.011 0.248 
Rmerge in top intensity bin  0.022 - - 
Total number of observations  72326 824 2402 
Total number unique  6947 114 495 
Mean((I)/sd(I))  35.3 70.9 2.6 
Mn(I) half-set correlation CC(1/2)  0.999 0.999 0.915 
Completeness  99.4 99.8 99.0 
Multiplicity  10.4 7.2 4.9 
    
Anomalous completeness  98.7 100.0 91.7 
Anomalous multiplicity  5.8 6.5 2.4 
DelAnom correlation between half-
sets  
0.474 0.659 0.081 
Mid-Slope of Anom Normal 
Probability  
1.020 - - 
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(D) Size exclusion of B + N0 
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(E)  OutD-N0 Mass spectrometry results 
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(F)   OutF Cloning Work – Shevchik laboratory 
 
 
 
 
 
 
 
 
 
 
Figure 1 Digestion of pGEX-6P-3 with Nde1 and EcoR1 
The OutF gene was to be cloned into the pGEX-6P-3 plasmid for expression. However, the 
intended vector already contained an insert at the expression site. So the existing insert was 
removed by double digestion with EcoR1 and Nde1 restriction endonucleases, shown in Figure 
2 above; a indicates the old insert, no longer required.   
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Figure 2 PCR amplification and ligation 
The OutF gene was amplified by PCR using appropriately designed primers (Lanes 1-4 right 
hand side).  
Ligation of the PCR product into pGEX-6P-3 vector is show left hand side lanes 1-6), a band 
of excess PCR product is still faintly visible. 
Double digested pGEX-6P-3 plasmid s shown in middle to the left of the marker 
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Figure 3 Expression of pGEX-6P-3:OutF 
The ligated constructed was the transformed into E. coli strain CD43(DE3) for expression. 
CD43(DE3) is a derivative of BL21(DE3) but is reported to overproduce transmembrane 
proteins with less toxicity (Miroux et al 1996). 
 
 
 
 
Bibliography 
 
142 
 
References 
Abendroth, J. et al., 2009. The three-dimensional structure of the cytoplasmic domains of 
EpsF from the type 2 secretion system of Vibrio cholerae. Journal of Structural 
Biology, 166(3), pp.303–315.  
Abendroth, J. et al., 2005. The X-ray structure of the type II secretion system complex 
formed by the N-terminal domain of EpsE and the cytoplasmic domain of EpsL of 
Vibrio cholerae. Journal of molecular biology, 348(4), pp.845–855. 
Adams, P.D. et al., 2010. PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta crystallographica. Section D, Biological 
crystallography, 66 (2), pp.213–221. 
Ast, V.M. et al., 2002. Expression of the ExeAB complex of Aeromonas hydrophila is 
required for the localization and assembly of the ExeD secretion port multimer. 
Molecular microbiology, 44 (1), pp.217–231. 
Ayers M., Howell P., Burrows L., 2010. Architecture of the type II secretion and type IV 
pilus machineries. Future Microbiol. 5 (8), pp.1203-1218.  
Bally, M. et al., 1992. Protein secretion in Pseudomonas aeruginosa: characterization of 
seven xcp genes and processing of secretory apparatus components by prepilin 
peptidase. Molecular microbiology, 6 (9), pp.1121–1131. 
Bouley, J., Condemine, G. & Shevchik, V.E., 2001. The PDZ domain of OutC and the N-
terminal region of OutD determine the secretion  specificity of the type II out 
pathway of Erwinia chrysanthemi. Journal of molecular biology, 308 (2), pp.205–219. 
Bibliography 
 
143 
 
Brahms S, Brahms J., 1980. Determination of protein secondary structure in solution by 
vacuum ultraviolet circular dichroism. J Mol Biol. 138 (2), pp.149-178. 
Camberg, J.L. et al., 2007. Synergistic stimulation of EpsE ATP hydrolysis by EpsL and 
acidic phospholipids. The EMBO journal, 26(1), pp.19–27. 
Camberg, J.L. & Sandkvist, M., 2005. Molecular analysis of the Vibrio cholerae type II 
secretion ATPase EpsE. Journal of bacteriology, 187(1), pp.249–256. 
Campos, M. et al., 2013. The type II secretion system - a dynamic fiber assembly 
nanomachine. Research in microbiology, 164(6), pp.545–555. 
Chami, M. et al., 2005. Structural insights into the secretin PulD and its trypsin-resistant 
core. The Journal of biological chemistry, 280(45), pp.37732–37741. 
Cianciotto, N.P., 2005. Type II secretion: a protein secretion system for all seasons. Trends 
in microbiology, 13 (12), pp.581–588. 
Collin S., Guilvout I., Nickerson N., Pugsley A., 2011. Sorting of an integral outer 
membrane protein via the lipoprotein-specific Lol pathway and a dedicated 
lipoprotein pilotin. Mol Microbiol. 80 (3), pp.655-665.  
Condemine, G. & Shevchik, V.E., 2000. Overproduction of the secretin OutD suppresses 
the secretion defect of an Erwinia chrysanthemi outB mutant. Microbiology 
(Reading, England), 146 (3), pp.639–647. 
D’Enfert, C. et al., 1989. Protein secretion by gram-negative bacteria. Characterization 
of two membrane proteins required for pullulanase secretion by Escherichia coli K-
12. The Journal of biological chemistry, 264 (29), pp.17462–17468. 
Bibliography 
 
144 
 
D’Enfert, C. & Pugsley, A.P., 1989. Klebsiella pneumoniae pulS gene encodes an outer 
membrane lipoprotein required for pullulanase secretion. Journal of bacteriology, 
171 (7), pp.3673–3679. 
Dalbey R., Wang P., Kuhn A., 2011. Assembly of bacterial inner membrane proteins. 
Annu Rev Biochem. 80, pp.161–187.  
Dessvaux M., Hébraud M., Talon R., Henderson I., 2009. Secretion and subcellular 
localizations of bacterial proteins: a semantic awareness issue. Trends Microbiol. 17 
(4), pp.139-145.  
Dolinsky, T.J. et al., 2007. PDB2PQR: expanding and upgrading automated preparation 
of biomolecular structures for molecular simulations. Nucleic acids research, 35, 
pp.522–525. 
Douzi, B. et al., 2011. Deciphering the Xcp Pseudomonas aeruginosa type II secretion 
machinery through multiple interactions with substrates. The Journal of biological 
chemistry, 286 (47), pp.40792–40801. 
Dunstan, R.A. et al., 2013. Assembly of the type II secretion system such as found in 
Vibrio cholerae depends on the novel Pilotin AspS. PLoS pathogens, 9 (1), 
p.e1003117. 
Durand, E. et al., 2005. XcpX controls biogenesis of the Pseudomonas aeruginosa XcpT-
containing pseudopilus. The Journal of biological chemistry, 280 (36), pp.31378–
31389. 
Emsley, P. et al., 2010. Features and development of Coot. Acta crystallographica. Section 
D, Biological crystallography, 66 (4), pp.486–501. 
Bibliography 
 
145 
 
Evans, P., 2006. Scaling and assessment of data quality. Acta crystallographica. Section D, 
Biological crystallography, 62 (1), pp.72–82. 
Facey S., Kuhn A., 2010. Biogenesis of bacterial inner-membrane proteins. Cell Mol Life 
Sci. 67 (14), pp.2343-2362. 
Farizo, K. M., Fiddner, S., Cheung, A. M. & Burns, D. L., 2002. Membrane localization 
of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for 
pertussis toxin secretion. Infect. Immun. 70, pp.1193–1201. 
Fröbel J., Rose P., Müller M., 2011. Early contacts between substrate proteins and TatA 
translocase component in twin-arginine translocation. J Biol Chem. 23, 286 (51), 
pp.43679-43689. 
Goujon, M. et al., 2010. A new bioinformatics analysis tools framework at EMBL-EBI. 
Nucleic acids research, 38, pp.695–699. 
Gray, M.D. et al., 2011. In vivo cross-linking of EpsG to EpsL suggests a role for EpsL as 
an ATPase-pseudopilin coupling protein in the Type II secretion system of Vibrio 
cholerae. Molecular microbiology, 79 (3), pp.786–798. 
Grys, T.E. et al., 2005. The StcE protease contributes to intimate adherence of 
enterohemorrhagic Escherichia coli O157:H7 to host cells. Infection and immunity, 
73 (3), pp.1295–1303. 
Gu, S., Kelly, G., et al., 2012a. Solution structure of homology region (HR) domain of type 
II secretion system. The Journal of biological chemistry, 287 (12), pp.9072–9080. 
Bibliography 
 
146 
 
Gu, S., Rehman, S., et al., 2012b. Structural and functional insights into the pilotin-
secretin complex of the type II secretion system. PLoS pathogens, 8 (2), p.e1002531. 
Guilvout I, Hardie KR, Sauvonnet N, Pugsley A, 1999. Genetic dissection of the outer 
membrane secretin PulD: are there distinct domains for multimerization and 
secretion specificity? J. Bacteriol. 181, pp.7212–7220. 
Guilvout I., Nickerson N., Chami M., Pugsley A.P., 2011. Multimerization-defective ts of 
dodecameric secretin PulD. Res Microbiol. 162 (2), pp.180-190. 
Gupta R. S., 2011. Origin of diderm (Gram-negative) bacteria: antibiotic selection 
pressure rather than endosymbiosis likely led to the evolution of bacterial cells with 
two membranes Antonie van Leeuwenhoek, 100, pp.171–182. 
Gupta R. S., 1998. Protein phylogenies and signature sequences: A reappraisal of 
evolutionary relationships among archaebacteria, eubacteria, and eukaryotes. 
Microbiol Mol Biol Rev, 62 (4), pp.1435–1491. 
Hachani, A., Lossi, N. S., Hamilton, A., Jones, C., Bleves, S., Albesa-Jové, D., & Filloux, 
A. 2011. Type VI Secretion System in Pseudomonas aeruginosa: Secretion and 
multimerisation of VgrG proteins. The Journal of Biological Chemistry, 286 (14), 
pp.12317–12327.  
Hardie K.R., Seydel A., Guilvout I., Pugsley A.P., 1996. The secretin-specific, chaperone-
like protein of the general secretory pathway: separation of proteolytic protection 
and piloting functions. Mol Microbiol. 22 (5), pp.967-976. 
Hauser, A.R., 2009. The Type III Secretion System of Pseudomonas aeruginosa: Infection 
by Injection. Nature Reviews. Microbiology, 7 (9), pp.654–665. 
Bibliography 
 
147 
 
Hirst T.R., Holmgren J., 1987. Conformation of protein secreted across bacterial outer 
membranes: a study of enterotoxin translocation from Vibrio cholerae. Proc Natl 
Acad Sci  84 (21), pp.7418-7422. 
Ho, C.S., Chan M., Cheung R., Law L., Lit L., Ng K., Suen M., and Tai H., 2003. 
Electrospray Ionisation Mass Spectrometry: Principles and Clinical Applications. 
Clin Biochem Rev 24 (1), pp.3–12.  
Hobot, J. A., E. Carlemalm, et al., 1984. Periplasmic gel: new concept resulting from the 
reinvestigation of bacterial cell envelope ultrastructure by new methods. J Bacteriol. 
160 (1): 143-152. 
Howard, S.P., 2013. Assembly of the Type II Secretion System. Research in 
Microbiologoy, 164 (6), pp.535–544.  
Johnson, T.L., Scott, M.E. & Sandkvist, M., 2007. Mapping critical interactive sites 
within the periplasmic domain of the Vibrio cholerae type II secretion protein EpsM. 
Journal of bacteriology, 189 (24), pp.9082–9089. 
Jones, H.E., Holland, I.B. & Campbell, A.K., 2002. Direct measurement of free Ca(2+) 
shows different regulation of Ca(2+) between the periplasm and the cytosol of 
Escherichia coli. Cell calcium, 32 (4), pp.183–192. 
Jyot, J., Balloy, V., Jouvion, G., Verma, A., Touqui, L., Huerre, M., Ramphal, R., 2011. 
Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a 
Significant Role in Death Due to Lung Infection. The Journal of Infectious Diseases, 
203 (10), pp.1369–1377.  
Bibliography 
 
148 
 
Kabsch, W. & Sander, C., 1983. Dictionary of protein secondary structure: pattern 
recognition of hydrogen-bonded and geometrical features. Biopolymers, 22 (12), 
pp.2577–2637. 
Karuppiah, V. et al., 2013. Structure and assembly of an inner membrane platform for 
initiation of type IV pilus biogenesis. Proceedings of the National Academy of Sciences 
of the United States of America, 110 (48), pp.E4638–47. 
Kelley, L.A. & Sternberg, M.J.E., 2009. Protein structure prediction on the Web: a case 
study using the Phyre server. Nature protocols, 4 (3), pp.363–371. 
Klein, D.W., Prescott, LM.; Harley, John (2005). Microbiology. Boston: McGraw-Hill 
Higher Education. ISBN 0-07-295175-3. 
Korotkov, K. V et al., 2009. Crystal structure of the N-terminal domain of the secretin 
GspD from ETEC determined with the assistance of a nanobody. Structure 17 (2), 
pp.255–265.  
Korotkov, K. V et al., 2006. Structural and functional studies of EpsC, a crucial 
component of the type 2 secretion system from Vibrio cholerae. Journal of molecular 
biology, 363 (2), pp.311–321. 
Korotkov, K. V et al., 2011. Structural and functional studies on the interaction of GspC 
and GspD in the type II secretion system. PLoS pathogens, 7(9), p.e1002228. 
Korotkov, K. V, Sandkvist, M. & Hol, W.G.J., 2012. The type II secretion system: 
biogenesis, molecular architecture and mechanism. Nature reviews. Microbiology, 10 
(5), pp.336–351. 
Bibliography 
 
149 
 
Krissinel, E. & Henrick, K., 2004. Secondary-structure matching (SSM), a new tool for 
fast protein structure alignment in three dimensions. Acta crystallographica. Section 
D, Biological crystallography, 60 (Pt 12), pp.2256–2268. 
Lallemand M, Login FH, Guschinskaya N, Pineau C, Effantin G, Robert X, Shevchik 
VE., 2013. Dynamic interplay between the periplasmic and transmembrane domains 
of GspL and GspM in the type II secretion system. PLoS One. 8 (11) pp.e79562 
Langer G., Cohen S.X., Lamzin V.S., Perrakis A., 2008. Automated macromolecular 
model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc., 
3 (7) pp.1171-1179.  
Larkin, M.A. et al., 2007. Clustal W and Clustal X version 2.0. Bioinformatics (Oxford, 
England), 23 (21), pp.2947–2948. 
Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M., 1993. PROCHECK - a 
program to check the stereochemical quality of protein structures. J. App. Cryst., 26, 
pp.283–291 
Lindeberg M., Salmond G., Collmer A., 1996. Complementation of deletion mutations in 
a cloned functional cluster of Erwinia chrysanthemi out genes with Erwinia 
carotovora out homologues reveals OutC and OutD as candidate gatekeepers of 
species-specific secretion of proteins via the type II pathway. Mol Microbiol. 20 (1) 
pp.175–190. 
Liu M., Mao X., Ye C., Huang H., Nicholson J., Lindon J., 1998. Improved 
WATERGATE Pulse Sequences for Solvent Suppression in NMR Spectroscopy, 
Journal of Magnetic Resonance, 132 (1), pp.125-129. 
Bibliography 
 
150 
 
Login, F.H. & Shevchik, V.E., 2006. The single transmembrane segment drives self-
assembly of OutC and the formation of a functional type II secretion system in 
Erwinia chrysanthemi. The journal of biological chemistry, 281 (44), pp.33152–33162. 
Lybarger, S.R. et al., 2009. Docking and assembly of the type II secretion complex of 
Vibrio cholerae. Journal of bacteriology, 191 (9), pp.3149–3161. 
Ma Q., Zhai Y., Schneider J.C., Ramseier T.M., Saier M.H., 2003. Protein secretion 
systems of Pseudomonas aeruginosa and P. fluorescens. Biochim Biophys Acta. 1611, 
pp.223-233. 
Martin, S. R. and Schilstra, M. J., 2008. Circular Dichroism and Its Application to the 
Study of Biomolecules." Methods in cell biology 84: pp.263-293. 
Martynowski, D. & Peter, S., 2013. Structure of a periplasmic domain of the EpsAB 
fusion protein of the Vibrio vulnificus type II secretion system research papers. PLoS 
One, pp.142–149. 
McBride M. J. & Zhu Y., 2013. Gliding Motility and Por Secretion System Genes Are 
Widespread among members of the Phylum Bacteroidetes Journal of Bacteriology 
195 (2), pp. 270 –278 
McCoy, A. J. et al., 2007. Phaser crystallographic software. Journal of applied 
crystallography, 40 (Pt 4), pp.658–674. 
McLaughlin, L.S., Haft, R.J.F. & Forest, K.T., 2012. Structural insights into the Type II 
secretion nanomachine. Current opinion in structural biology, 22(2), pp.208–216. 
Bibliography 
 
151 
 
Miroux B, Walker J., 1996. Over-production of proteins in Escherichia coli: mutant hosts 
that allow synthesis of some membrane proteins and globular proteins at high levels. 
J Mol Biol, 260:289-98. 
Misic, A.M., Satyshur, K.A. & Forest, K.T., 2010. P. aeruginosa PilT Structures with and 
without Nucleotide Reveal a Dynamic Type IV Pilus Retraction Motor. Journal of 
Molecular Biology, 400 (5), pp.1011–1021.  
Muhlradt, P.F. & Golecki, J.R., 1975. Asymmetrical distribution and artifactual 
reorientation of lipopolysaccharide in  the outer membrane bilayer of Salmonella 
typhimurium. European journal of biochemistry / FEBS, 51 (2), pp.343–352. 
Nivaskumar, M. & Francetic, O., 2014. Biochimica et Biophysica Acta Type II secretion 
system : A magic beanstalk or a protein escalator. BBA - Molecular Cell Research, 
1843 (8), pp.1568–1577.  
Pauwels, K., Lustig A., Wyns L., Tommassen J., Savvides S.N., Van Gelder P., 2006. 
Structure of a membrane-based steric chaperone in complex with its lipase substrate. 
Nature structural & molecular biology, 13 (4), pp.374–375. 
Palomäki T., Pickersgill R., Riekki R., Romantschuk M., Saarilahti H.T., 2002.  A 
putative three-dimensional targeting motif of polygalacturonase (PehA), a protein 
secreted through the type II (GSP) pathway in Erwinia carotovora. Mol Microbiol. 
43 (3), pp.585-596. 
Peabody, C.R. et al., 2003. Type II protein secretion and its relationship to bacterial type 
IV pili and archaeal flagella. Microbiology (Reading, England), 149 (Pt 11), pp.3051–
3072. 
Bibliography 
 
152 
 
Piddock, L., 2006. Multidrug-resistance efflux pumps? Not just for resistance. Nat Rev 
Micro 4 (8): 629-636. 
Pineau C, Guschinskaya N, Robert X, Gouet P, Ballut L, Shevchik VE., 2014. Substrate 
recognition by the bacterial type II secretion system: more than a simple 
interaction, Molecular Microbiology, 94, pp.126-140. 
Pugsley, A.P., Kornacker, M.G. & Poquet, I., 1991. The general protein-export pathway 
is directly required for extracellular pullulanase secretion in Escherichia coli K12. 
Molecular microbiology, 5 (2), pp.343–352. 
Pugsley A.P., Reyss I., 1990. Five genes at the 3′ end of the Klebsiella pneumoniae pulC 
operon are required for pullulanase secretion Molecular microbiology, 4 (3), pp. 
365–379. 
Reichow, S.L. et al., 2010. Structure of the cholera toxin secretion channel in its closed 
state. Nature structural & molecular biology, 17 (10), pp.1226–1232. 
Reichow, S.L. et al., 2011. The binding of cholera toxin to the periplasmic vestibule of the 
type II secretion channel. Channels (Austin, Tex.), 5 (3), pp.215–218. 
Robert, V. et al., 2002. Identification of XcpZ Domains Required for Assembly of the 
Secreton of Pseudomonas aeruginosa. Journal of Bacteriology, 184 (6), pp.1779–1782. 
Rondelet, A. & Condemine, G., 2013. Type II secretion : the substrates that won ’ t go 
away. Research in Microbiologoy, 164 (6), pp.556–561.  
Bibliography 
 
153 
 
Rossier, O., Starkenburg, S.R. & Cianciotto, N.P., 2004. Legionella pneumophila type II 
protein secretion promotes virulence in the A/J mouse model of Legionnaires’ 
disease pneumonia. Infection and immunity, 72 (1), pp.310–321. 
Sandkvist, M. et al., 1995. Interaction between the autokinase EpsE and EpsL in the 
cytoplasmic membrane is required for extracellular secretion in Vibrio cholerae. The 
EMBO journal, 14 (8), pp.1664–1673. 
Sandkvist, M., 2001. Type II secretion and pathogenesis. Infection and immunity, 69 (6), 
pp.3523–3535. 
Schraidt O., Lefebre M.D., Brunner M.J., 2010. Topology and organization of the 
Salmonella typhimurium type III secretion needle complex components. PLoS 
Pathogens, 1 (6), pp.e1000824.  
Shevchik VE1, Condemine G. 1998. Functional characterization of the Erwinia 
chrysanthemi OutS protein, an element of a type II secretion system. Microbiology, 
144 (11), pp.3219–3228. 
Shiue, S.J. et al., 2006. XpsE oligomerization triggered by ATP binding, not hydrolysis, 
leads to its association with XpsL. The EMBO journal, 25 (7), pp.1426–1435. 
Strozen, T.G. et al., 2011. Involvement of the GspAB complex in assembly of the type II 
secretion system secretin of Aeromonas and Vibrio species. Journal of bacteriology, 
193 (9), pp.2322–2331. 
Thomas, J.D., Reeves, P.J. & Salmond, G.P.C., 1997. The general secretion pathway of 
Erwinia carotovora subsp. carotovora: analysis of the membrane topology of OutC 
and OutF. Microbiology, 143 (3), pp.713–720.  
Bibliography 
 
154 
 
Vanderlinde, E.M. et al., 2014. Assembly of the type two secretion system in Aeromonas 
hydrophila involves direct interaction between the periplasmic domains of the 
assembly factor ExeB and the secretin ExeD. PloS one, 9 (7), p.e102038. 
Walker, P.A. Leong L., Ng P., et al., 1994. Efficient and rapid affinity purification of 
proteins using recombinant fusion proteases. Biotechnology 12 (6), pp.601-605. 
Wang, X. et al., 2012. Cysteine scanning mutagenesis and disulfide mapping analysis of 
arrangement of GspC and GspD protomers within the type 2 secretion system. The 
Journal of biological chemistry, 287 (23), pp.19082–19093. 
Weiss, A. A., Johnson, F. D. & Burns, D. L., 1993. Molecular characterization of an 
operon required for pertussis toxin secretion. Proc. Natl Acad. Sci. USA, 90,  
pp. 2970–2974. 
Winn M.D., Murshudov G.N., Papiz M.Z., 2003. Macromolecular TLS refinement in 
REFMAC at moderate resolutions. Methods in Enzymology, 374, pp.300-321. 
Winter, G., Lobley, C.M.C. & Prince, S.M., 2013. Decision making in xia2. Acta 
crystallographica. Section D, Biological crystallography, 69 (7), pp.1260–1273. 
Yamashita, M., Fenn., 1984. Electrospray ion source. Another variation on the free-jet 
theme. Journal of Physical Chemistry, 88 (20), pp.4451–4459. 
Yang S., Peng Q., Francisco M., Wang Y., Zeng Q., et al., 2008. Type III Secretion System 
Genes of Dickeya dadantii 3937 Are Induced by Plant Phenolic Acids. PLoS ONE, 3 
(8) pp.e2973   
Bibliography 
 
155 
 
Zechner E., Lang S., and Schildbach J., 2012.  Assembly and mechanisms of bacterial 
type IV secretion machines Philos Trans R Soc Lond B Biol Sci. 367 (1592), pp.1073–
1087. 
 
